Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 630 articles:
HTML format



Single Articles


    November 2024
  1. MAQSOOD MH, Tamis-Holland JE, Feit F, Bangalore S, et al
    Revisiting the Efficacy and Safety of Bivalirudin in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials.
    Catheter Cardiovasc Interv. 2024 Nov 6. doi: 10.1002/ccd.31276.
    PubMed     Abstract available


  2. CARLINO M, Nascimbene A, Brilakis ES, Yarrabothula A, et al
    HydroDynamic contrast Recanalization (HDR): Description of a new crossing technique for coronary chronic total occlusions.
    Catheter Cardiovasc Interv. 2024;104:918-927.
    PubMed     Abstract available


  3. GASPARINI GL, Maurina M, Regazzoli D, Canova P, et al
    The "Cuttering (Cutting-Dottering Balloon) Technique" for treatment of flow-limiting coronary intramural hematoma.
    Catheter Cardiovasc Interv. 2024;104:952-958.
    PubMed     Abstract available


  4. OLIVERI F, Meijer M, Van Oort MJH, Al Amri I, et al
    Procedural and clinical impact of intracoronary lithotripsy in heavily calcified aorto-ostial coronary lesions.
    Catheter Cardiovasc Interv. 2024;104:881-890.
    PubMed     Abstract available


  5. ASHIKAGA T, Lee T, Miyazaki R, Nagase M, et al
    Methods for treating coronary eruptive calcified nodules.
    Catheter Cardiovasc Interv. 2024;104:899-906.
    PubMed     Abstract available


  6. WEI P, Pu Z, Chan JSK, Li Y, et al
    Outcomes of transcatheter closure for coronary artery fistulas with or without aneurysm: A comparative study.
    Catheter Cardiovasc Interv. 2024;104:990-998.
    PubMed     Abstract available


  7. FARIA D, Lombardi M, van der Hoeven N, Travieso A, et al
    Age-related structural remodelling of the coronary circulation.
    Catheter Cardiovasc Interv. 2024;104:968-979.
    PubMed     Abstract available


  8. WILGENHOF A, Jukema RA, Driessen RS, Danad I, et al
    The effect of hydrostatic pressure on invasive coronary pressure measurements: Comparison with [(15)O]H(2)O-positron emission tomography flow data.
    Catheter Cardiovasc Interv. 2024;104:980-989.
    PubMed     Abstract available


  9. SAVAGE ML, Hay K, Vollbon W, Murdoch DJ, et al
    Differences between sexes in STEMI treatment and outcomes with contemporary primary PCI.
    Catheter Cardiovasc Interv. 2024;104:934-944.
    PubMed     Abstract available


  10. BRLANSKY J, Qiu D, Azadani AN
    Laser ablation for preventing coronary obstruction and maintaining coronary access in redo-TAVR: A proof of concept.
    Catheter Cardiovasc Interv. 2024;104:1086-1095.
    PubMed     Abstract available


    October 2024
  11. ONG PJL, Chui SF, Tam FC, Nguyen QT, et al
    Polymer free biolimus coated stents to treat acute ST-elevation myocardial infarction in Asian patients.
    Catheter Cardiovasc Interv. 2024 Oct 21. doi: 10.1002/ccd.31263.
    PubMed     Abstract available


  12. BOSA OJEDA F, Mendez Vargas C, Lacalzada Almeida J, Izquierdo Gomez MM, et al
    Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial.
    Catheter Cardiovasc Interv. 2024 Oct 19. doi: 10.1002/ccd.31267.
    PubMed     Abstract available


  13. KINNAIRD T, Gallagher S, Farooq V, Protty MB, et al
    In-hospital outcomes of ad hoc versus planned PCI for unprotected left-main disease: An analysis of 8574 cases from British Cardiovascular Intervention Society database 2006-2018.
    Catheter Cardiovasc Interv. 2024;104:697-706.
    PubMed     Abstract available


  14. GUPTA A, Shrivastava A, Chhikara S, Revaiah PC, et al
    Safety, efficacy, and optical coherence tomography insights into intravascular lithotripsy for the modification of non-eruptive calcified nodules: A prospective observational study.
    Catheter Cardiovasc Interv. 2024;104:688-696.
    PubMed     Abstract available


  15. WANG X, Zhang H, Bai X, Zhang L, et al
    Practices and outcomes of rotational atherectomy in China: The Rota China registry.
    Catheter Cardiovasc Interv. 2024;104:664-675.
    PubMed     Abstract available


  16. FELBEL D, Fattom A, Fechter I, Paukovitsch M, et al
    Kidney disease, diabetes, and diameter stenosis predict Rotablation bailout in modified balloon application for severely calcified coronary lesions.
    Catheter Cardiovasc Interv. 2024;104:676-687.
    PubMed     Abstract available


  17. SAWANT AC, Patel N, Pershad A
    Safety, feasibility, and incremental value of ultralow and zero contrast PCI in an all-comers registry.
    Catheter Cardiovasc Interv. 2024;104:648-654.
    PubMed     Abstract available


  18. OLIVERI F, van Oort MJH, Al Amri I, Bingen BO, et al
    Intravascular lithotripsy in heavily calcified chronic total occlusion: procedural and one-year clinical outcomes.
    Catheter Cardiovasc Interv. 2024;104:655-663.
    PubMed     Abstract available


  19. MADANAT L, Jabri A, Sankar P, Safian RD, et al
    Use of biliary stents for large coronary arteries.
    Catheter Cardiovasc Interv. 2024;104:751-754.
    PubMed     Abstract available


  20. RAB T
    No time to wait in cardiogenic shock!
    Catheter Cardiovasc Interv. 2024;104:773-774.
    PubMed    


  21. ROUMELIOTIS A, Siasos G, Dangas G, Power D, et al
    Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention.
    Catheter Cardiovasc Interv. 2024;104:723-732.
    PubMed     Abstract available


    September 2024
  22. ZAFIROVSKA B, Jovkovski A, Vasilev I, Taravari H, et al
    Sex differences in transradial access failure in ST segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2024 Sep 30. doi: 10.1002/ccd.31247.
    PubMed     Abstract available


  23. KANZAKI Y, Ueki Y, Sunohara D, Okina Y, et al
    Impact of multiple ballooning on coronary lesions as assessed by optical coherence tomography and intravascular ultrasound.
    Catheter Cardiovasc Interv. 2024 Sep 22. doi: 10.1002/ccd.31239.
    PubMed     Abstract available


  24. KOCH T, Lenz T, Rheude T, Cassese S, et al
    Comparative long-term efficacy and safety of two paclitaxel-coated balloons with different coating strategies for the treatment of drug-eluting coronary stent restenosis.
    Catheter Cardiovasc Interv. 2024 Sep 18. doi: 10.1002/ccd.31228.
    PubMed     Abstract available


  25. BAWAMIA B, Kuzemczak M, Lipiecki J, Legutko J, et al
    The role of intra-vascular imaging in patients undergoing intravascular lithotripsy: Insights from the COIL registry.
    Catheter Cardiovasc Interv. 2024 Sep 15. doi: 10.1002/ccd.31227.
    PubMed     Abstract available


  26. LAN NSR, Chih H, Brennan AL, Dwivedi G, et al
    Clinical outcomes and coronary artery lesion characteristics of young patients with ST elevation myocardial infarction and no standard modifiable risk factors.
    Catheter Cardiovasc Interv. 2024 Sep 9. doi: 10.1002/ccd.31205.
    PubMed     Abstract available


  27. DESHPANDE S, Sawatari H, Rangan K, Buchade A, et al
    Pericardial tamponade in coronary interventions: Morbidity and mortality.
    Catheter Cardiovasc Interv. 2024 Sep 9. doi: 10.1002/ccd.31213.
    PubMed     Abstract available


  28. MEW C, Dahiya A, Chong AA, Hayman SM, et al
    First-in-human: Leaflet laceration with balloon mediated annihilation to prevent coronary obstruction with radiofrequency needle (LLAMACORN) for valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Sep 3. doi: 10.1002/ccd.31195.
    PubMed     Abstract available


  29. ABUSNINA W, Merdler I, Deible R, Salimes BG, et al
    Experience and perspective with intravascular imaging and invasive coronary physiology: Insights from allied health professionals.
    Catheter Cardiovasc Interv. 2024 Sep 2. doi: 10.1002/ccd.31175.
    PubMed     Abstract available


  30. LAUKKANEN JA, Kunutsor SK, Immonen J, Hernesniemi J, et al
    Diabetes and mortality risk in patients undergoing coronary angiography: The KARDIO study.
    Catheter Cardiovasc Interv. 2024 Sep 2. doi: 10.1002/ccd.31212.
    PubMed     Abstract available


    August 2024
  31. YOUNES AM, Hashem A, Maraey A, Khalil M, et al
    Outcomes among patients with non-ST-elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2024 Aug 27. doi: 10.1002/ccd.31198.
    PubMed     Abstract available


  32. LE Q, Hirai T, Lombardi WL, Azzalini L, et al
    Use of dual-lumen microcatheter pullback injection in complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Aug 13. doi: 10.1002/ccd.31180.
    PubMed     Abstract available


  33. GRUSLOVA AB, Feldman MD
    Can ethylene diamine tetra-acetic acid improve calcium fracture when combined with intravascular lithotripsy?
    Catheter Cardiovasc Interv. 2024;104:423-424.
    PubMed    


  34. OKAMOTO A, Yamaguchi T, Yamazaki T, Fukuda D, et al
    Successful revascularization of coronary occlusion due to lotus root-like plaques by IVUS-based real-time three-dimensional wiring using the tip detection method in a patient with cardiac arrest.
    Catheter Cardiovasc Interv. 2024;104:252-255.
    PubMed     Abstract available


  35. KACHI D, Lee T, Terui M, Nagase M, et al
    The impact of novel scoring balloon and cutting balloon after orbital atherectomy on severely calcified coronary lesion as assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2024;104:213-219.
    PubMed     Abstract available


  36. VIZZARI G, Caminiti R, Ielasi A, Vetta G, et al
    Contrast-enhanced excimer laser stepwise approach during PCI for resistant coronary lesions.
    Catheter Cardiovasc Interv. 2024;104:220-226.
    PubMed     Abstract available


  37. VAN OORT MJH, Al Amri I, Bingen BO, Oliveri F, et al
    Current applications, procedural and 1-year outcomes of Rotatripsy for the treatment of calcified coronary lesions.
    Catheter Cardiovasc Interv. 2024;104:203-212.
    PubMed     Abstract available


  38. CIZGICI AY, Guner A, Alizade E, Cetin I, et al
    Cardiovascular outcomes of complex bifurcation lesions following double kissing crush or nano-crush techniques: The multicenter EVOLUTE-CRUSH V study.
    Catheter Cardiovasc Interv. 2024;104:191-202.
    PubMed     Abstract available


  39. DEMANDT JPA, El Farissi M, de Vos A, Eerdekens R, et al
    Continuous thermodilution and microvascular resistance reserve during the index procedure in acute coronary syndrome without obstructive coronary artery disease: A pilot study.
    Catheter Cardiovasc Interv. 2024;104:241-246.
    PubMed     Abstract available


  40. CHATURVEDI A, Haberman D, Waksman R, Bernardo NL, et al
    Percutaneous intervention of a giant native coronary artery aneurysm using self-expanding stents.
    Catheter Cardiovasc Interv. 2024;104:247-251.
    PubMed     Abstract available


    July 2024
  41. MURTHI M, Prasath N, Memdani A, Bobba A, et al
    Comparison of in-hospital outcomes of ST-elevation myocardial infarction patients with cardiogenic shock receiving left ventricular mechanical circulatory support devices based on transfer status.
    Catheter Cardiovasc Interv. 2024 Jul 31. doi: 10.1002/ccd.31169.
    PubMed     Abstract available


  42. WATANABE Y, Naganuma T, Chieffo A, Montorfano M, et al
    Percutaneous coronary intervention for unprotected left main distal bifurcation lesions in elderly people.
    Catheter Cardiovasc Interv. 2024 Jul 10. doi: 10.1002/ccd.31133.
    PubMed     Abstract available


  43. LOCHY S, Galloo X, Droogmans S, Eeckhout E, et al
    Paravalvular leak closure of a native aortic valve for cardiogenic shock post valvular surgery.
    Catheter Cardiovasc Interv. 2024 Jul 6. doi: 10.1002/ccd.31144.
    PubMed     Abstract available


  44. HINTON J, Tuffs C, Varma R, Hurwitz-Bremner R, et al
    An analysis of long-term clinical outcome following the use of excimer laser coronary atherectomy in a large UK PCI center.
    Catheter Cardiovasc Interv. 2024;104:27-33.
    PubMed     Abstract available


  45. GALASSI AR, Vadala G
    Trends and evolution of antegrade dissection and re-entry technique: A glimpse into the future of complex chronic total occlusions interventions.
    Catheter Cardiovasc Interv. 2024;104:167-169.
    PubMed    


  46. VAN VLIET D, Ploumen EH, Pinxterhuis TH, Buiten RA, et al
    Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent.
    Catheter Cardiovasc Interv. 2024;104:1-9.
    PubMed     Abstract available


    June 2024
  47. SEKERAK R, Lerner JB, Garnett C, McEntegart M, et al
    Outcomes of ultra-low contrast percutaneous coronary intervention in patients with advanced chronic kidney disease.
    Catheter Cardiovasc Interv. 2024 Jun 26. doi: 10.1002/ccd.31128.
    PubMed     Abstract available


    May 2024
  48. ROHM CL, Pasrija C, Raj LM
    Percutaneous axillary extracorporeal membrane oxygenation supported complex left main bifurcation percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 May 25. doi: 10.1002/ccd.31113.
    PubMed     Abstract available


  49. ELWANY M, Dawood M, Shakhlab A, Sadaka M, et al
    Current alternatives to traditional radial approach for coronary interventions: A randomized prospective study of the ulnar and distal radial approaches.
    Catheter Cardiovasc Interv. 2024 May 7. doi: 10.1002/ccd.31071.
    PubMed     Abstract available


  50. YE C, Ma X, Shi B, Yan R, et al
    Obesity is associated with acute kidney injury in ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention: A national representative cohort study.
    Catheter Cardiovasc Interv. 2024;103:897-908.
    PubMed     Abstract available


  51. GIACOBBE F, Valente E, Morena A, Nebiolo M, et al
    Safety and efficacy of drug-eluting stents for patients at high risk of bleedings: A network meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:843-855.
    PubMed     Abstract available


  52. SATO T, Matsumura M, Yamamoto K, Shlofmitz E, et al
    Prevalence and anatomical factors associated with stent under-expansion in non-severely calcified lesions.
    Catheter Cardiovasc Interv. 2024;103:833-842.
    PubMed     Abstract available


  53. CASE BC, Bazarbashi N, Johnson A, Rogers T, et al
    A novel approach to saline/contrast delivery in excimer laser coronary atherectomy (ELCA) to enhance efficacy: MAXCon ELCA technique.
    Catheter Cardiovasc Interv. 2024;103:917-923.
    PubMed     Abstract available


  54. SAKAI K, Storozhenko T, Mizukami T, Ohashi H, et al
    Impact of vessel volume on thermodilution measurements in patients with coronary microvascular dysfunction.
    Catheter Cardiovasc Interv. 2024;103:885-896.
    PubMed     Abstract available


    April 2024
  55. DAMARKUSUMA A, Johar S, Patel B, Yung CC, et al
    Using Ping-pong technique along with rapid inflate-deflate ballooning to solve total left main occlusion during transcatheter aortic valve replacement procedure.
    Catheter Cardiovasc Interv. 2024 Apr 19. doi: 10.1002/ccd.31059.
    PubMed     Abstract available


  56. SPIRITO A, Gao M, Sartori S, Vogel B, et al
    Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians.
    Catheter Cardiovasc Interv. 2024 Apr 19. doi: 10.1002/ccd.31055.
    PubMed     Abstract available


  57. REMPAKOS A, Alexandrou M, Mutlu D, Choi JW, et al
    Validation of the BCIS CHIP Score in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Apr 17. doi: 10.1002/ccd.31045.
    PubMed     Abstract available


  58. BUCHANAN CE, Iskander M, Anwaruddin S, Mason PJ, et al
    Novel valve-in-surgical bioprosthetic transcatheter aortic valve replacement: Undermining iatrogenic coronary obstruction with radiofrequency needle (UNICORN).
    Catheter Cardiovasc Interv. 2024 Apr 8. doi: 10.1002/ccd.31038.
    PubMed     Abstract available


  59. AL-OGAILI A, Alexandrou M, Rempakos A, Mutlu D, et al
    Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31019.
    PubMed     Abstract available


  60. MERDLER I, Wallace R, Banerjee A, Medranda GA, et al
    Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects.
    Catheter Cardiovasc Interv. 2024;103:703-709.
    PubMed     Abstract available


  61. BASAVARAJAIAH S
    Drug coated balloons in large de novo vessels; fantasy or a reality?
    Catheter Cardiovasc Interv. 2024;103:819-820.
    PubMed    


  62. SUZUKI N
    Exploring the best strategy for true bifurcation coronary diseases to avoid a "fall between two stools".
    Catheter Cardiovasc Interv. 2024;103:817-818.
    PubMed    


  63. SAGRIS M, Ktenopoulos N, Dimitriadis K, Papanikolaou A, et al
    Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: A multicenter systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:710-721.
    PubMed     Abstract available


  64. LEI J, Pu H, Zhang L, Zeng C, et al
    Drug-coated balloon therapy for in-stent restenosis in patients with iliofemoral deep vein thrombosis: A single-arm observational study.
    Catheter Cardiovasc Interv. 2024;103:752-757.
    PubMed     Abstract available


  65. SANTOS LM, Campos CM, Garcia-Garcia HM, Godinho RR, et al
    Concordance between vessel-specific and vascular territory coronary functional assessment: A comparison of quantitative flow ratio and myocardial perfusion scintigraphy.
    Catheter Cardiovasc Interv. 2024 Apr 1. doi: 10.1002/ccd.31021.
    PubMed     Abstract available


    March 2024
  66. GIORDANO A, Biondi-Zoccai G
    Which is the best approach for percutaneous coronary intervention of chronic total occlusions? The one you feel most confident with!
    Catheter Cardiovasc Interv. 2024 Mar 20. doi: 10.1002/ccd.31011.
    PubMed    


  67. VELAGALETI RS, Harrell C, Michalski J, Lefevre T, et al
    Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Mar 5. doi: 10.1002/ccd.30995.
    PubMed     Abstract available


  68. FILHO EM, Araujo GN, Machado GP, Padilla L, et al
    Guide catheter extension use are associated with higher procedural success in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2024 Mar 3. doi: 10.1002/ccd.30987.
    PubMed     Abstract available


  69. SOLA M, Kay J, Messenger J, Zablah J, et al
    Transcatheter closure of a large coronary cameral fistula presenting as a calcified cystic right atrial mass.
    Catheter Cardiovasc Interv. 2024;103:607-611.
    PubMed     Abstract available


  70. SCIAHBASI A, Salvi N, Heang TM, Perez IS, et al
    Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels.
    Catheter Cardiovasc Interv. 2024;103:532-538.
    PubMed     Abstract available


  71. SCHELLER B
    Drug-coated balloons for complex coronary de novo lesions.
    Catheter Cardiovasc Interv. 2024;103:688-689.
    PubMed    


  72. ALEKSANDRIC S, Beleslin B
    Editorial comment: SYNTAX score II 2020 as a tool for decision making on revascularization strategy in high-risk patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2024;103:680-681.
    PubMed    


  73. POLETTI E, Zivelonghi C, Dens J, Bennett J, et al
    Performance of the minimalistic hybrid approach algorithm versus other conventional algorithms in the percutaneous treatment of chronic total occlusions.
    Catheter Cardiovasc Interv. 2024;103:548-559.
    PubMed     Abstract available


    February 2024
  74. PENG S, Rempakos A, Mastrodemos OC, Rangan BV, et al
    Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.30994.
    PubMed     Abstract available


  75. CORCIONE N, Biondi-Zoccai G
    ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease.
    Catheter Cardiovasc Interv. 2024 Feb 22. doi: 10.1002/ccd.30982.
    PubMed    


  76. SPIRITO A, Cohen R, Sartori S, Vogel B, et al
    Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 5. doi: 10.1002/ccd.30960.
    PubMed     Abstract available


  77. JEYAPRAKASH P, Mikhail P, Ford TJ, Pathan F, et al
    Index of Microcirculatory Resistance to predict microvascular obstruction in STEMI: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:249-259.
    PubMed     Abstract available


  78. MATTER MA, Candreva A, Stahli BE, Heg D, et al
    Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-study.
    Catheter Cardiovasc Interv. 2024;103:286-294.
    PubMed     Abstract available


  79. MOSCARDELLI S, Condos G, Lombardi WL, Azzalini L, et al
    Intracoronary snaring of the retrograde guidewire: A novel method to solve compartment mismatch in complex retrograde CTO PCI.
    Catheter Cardiovasc Interv. 2024;103:435-442.
    PubMed     Abstract available


  80. FUNATSU A, Sato T, Koike J, Mizobuchi M, et al
    Comprehensive clinical outcomes of drug-coated balloon treatment for coronary artery disease. Insights from a single-center experience.
    Catheter Cardiovasc Interv. 2024;103:404-416.
    PubMed     Abstract available


  81. LI M, Liu X, Jiang M, Lei Y, et al
    External validation of the SYNTAX score II 2020 in patients with chronic renal insufficiency.
    Catheter Cardiovasc Interv. 2024;103:391-403.
    PubMed     Abstract available


  82. KALRA R, Alexy T, Bartos JA, Prisco AR, et al
    Left ventricular hemodynamics with veno-arterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2024;103:472-481.
    PubMed     Abstract available


    January 2024
  83. VOLET C, Puricel S, Cook ST, di Cicco P, et al
    Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30961.
    PubMed     Abstract available


  84. SINGH K, Niranjan S, Hibbert B, Taramasso M, et al
    A stepwise approach to coronary artery stenting in acute type A aortic dissection.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30964.
    PubMed     Abstract available


  85. CHICHAREON P, Chamnarnphol N, Chandavimol M, Suwannasom P, et al
    Updated CRUSADE score to predict in-hospital bleeding: External validation in the Thai percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2024 Jan 14. doi: 10.1002/ccd.30940.
    PubMed     Abstract available


  86. JONES D, Spirito A, Sartori S, Vogel B, et al
    Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Jan 3. doi: 10.1002/ccd.30939.
    PubMed     Abstract available


  87. KAWAMURA A, Egami Y, Okamoto N, Kawanami S, et al
    Difference between antegrade and retrograde orbital atherectomy system debulking using an artificial pulsatile heart model.
    Catheter Cardiovasc Interv. 2024;103:42-50.
    PubMed     Abstract available


  88. SHEKILADZE N, Sandesara PB, Tai Z, Maisuradze N, et al
    Technical aspects of entrapped coronary guidewire retrieval using rotational atherectomy device: A case series.
    Catheter Cardiovasc Interv. 2024;103:89-96.
    PubMed     Abstract available


  89. GUPTA A, Shrivastava A, Chhikara S, Mamas MA, et al
    Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study).
    Catheter Cardiovasc Interv. 2024;103:51-60.
    PubMed     Abstract available


  90. UNGUREANU C, Cocoi M, Colletti G, Avran A, et al
    Successful treatment by recross IVUS-guided reentry in coronary total occlusion: STRIVE-CTO.
    Catheter Cardiovasc Interv. 2024;103:68-79.
    PubMed     Abstract available


    December 2023
  91. SAITO T, Kuno T, Ueyama HA, Kampaktsis PN, et al
    Transcatheter edge-to-edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Dec 29. doi: 10.1002/ccd.30944.
    PubMed     Abstract available


  92. HANSON I, Goldstein JA
    Percutaneous coronary intervention: Before, after, or during TAVR?
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30941.
    PubMed    


  93. AROW Z, Konigstein M, Vaknin-Assa H, Witberg G, et al
    Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Dec 14. doi: 10.1002/ccd.30924.
    PubMed     Abstract available


  94. NOORI M, Christiansen EH, Raungaard B, Junker A, et al
    Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Dec 13. doi: 10.1002/ccd.30937.
    PubMed     Abstract available


  95. PIEDIMONTE G, Azzalini L, Ferrarotto L, Mangione R, et al
    Applicability of J-CTO channel score to predict microcatheter tracking during retrograde percutaneous coronary intervention of chronic total occlusions: Insights from the SURFING MICRO registry.
    Catheter Cardiovasc Interv. 2023 Dec 4. doi: 10.1002/ccd.30928.
    PubMed     Abstract available


  96. DE SILVA K, Li Kam Wa ME, Wells T, Mozid A, et al
    The everolimus eluting Synergy Megatron(TM) drug-eluting stent platform: Early outcomes from the European Synergy Megatron(TM) Implanters' Registry.
    Catheter Cardiovasc Interv. 2023;102:1222-1228.
    PubMed     Abstract available


  97. BASAVARAJAIAH S, Kalkat H, Bhatia G, Cortese B, et al
    How to perform a successful drug-coated balloon angioplasty? Tips and tricks.
    Catheter Cardiovasc Interv. 2023;102:1238-1257.
    PubMed     Abstract available


  98. MOVAHED MR
    Movahed coronary bifurcation classification should be the preferred classification for studying true bifurcation lesions as it summarizes true bifurcation lesions in only one simple category called B2 Lesion with limitless optional suffixes.
    Catheter Cardiovasc Interv. 2023;102:1263-1264.
    PubMed    


  99. RANA MOR, Habib A, Sheikh MAA, Ayub S, et al
    Outcomes of European Society of Cardiology 0/1-h algorithm with high-sensitivity cardiac troponin T among patients with coronary artery disease.
    Catheter Cardiovasc Interv. 2023;102:1155-1161.
    PubMed     Abstract available


  100. ORZALKIEWICZ M, Bruno AG, Saia F, Palmerini T, et al
    A novel high-risk aortic root anatomy for right coronary artery occlusion during TAVI.
    Catheter Cardiovasc Interv. 2023;102:1389-1392.
    PubMed     Abstract available


  101. MATHEW RO, Rangaswami J, Abramov D, Mahalwar G, et al
    Proportional troponin changes and risk for outcomes with intervention strategies in non-ST-elevation acute coronary syndrome across kidney function.
    Catheter Cardiovasc Interv. 2023;102:1162-1176.
    PubMed     Abstract available


  102. YAYLAK B, Polat F, Onuk T, Akyuz S, et al
    The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long-term cardiovascular events.
    Catheter Cardiovasc Interv. 2023;102:1186-1197.
    PubMed     Abstract available


    November 2023
  103. JAVAID AI, Michalek JE, Gruslova AB, Hoskins SA, et al
    Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Nov 23. doi: 10.1002/ccd.30913.
    PubMed     Abstract available


  104. GARBO R, Iannaccone M, Bruno F, Arioti M, et al
    Intravascular ultrasound-guided STAR 2.0: A new technique for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30920.
    PubMed     Abstract available


  105. SIMSEK B, Rempakos A, Kostantinis S, Alexandrou M, et al
    International survey of chronic total occlusion percutaneous coronary intervention operators.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30914.
    PubMed     Abstract available


  106. NUMASAWA Y, Sawano M, Ishii H, Kohsaka S, et al
    One-year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J-PCI OUTCOME registry.
    Catheter Cardiovasc Interv. 2023 Nov 9. doi: 10.1002/ccd.30895.
    PubMed     Abstract available


  107. LIU X, Zhang Y, Xu Y, Tang Z, et al
    Fractional flow reserve versus intravascular imaging to guide decision-making for percutaneous coronary intervention in intermediate lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2023 Nov 8. doi: 10.1002/ccd.30909.
    PubMed     Abstract available


  108. COZZI O, Maurina M, Cacia M, Bernardini V, et al
    Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery.
    Catheter Cardiovasc Interv. 2023 Nov 7. doi: 10.1002/ccd.30903.
    PubMed     Abstract available


  109. ALADIN AI, Wermers JP, Zhang C, Case BC, et al
    Prognostic implication of hemoglobin reduction with and without clinical bleeding after percutaneous coronary intervention in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Nov 5. doi: 10.1002/ccd.30896.
    PubMed     Abstract available


  110. EL KHOURY A, Lazar L, Cortese B
    The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.
    Catheter Cardiovasc Interv. 2023;102:979-986.
    PubMed     Abstract available


  111. SANDESARA PB, Elhage Hassan M, Shekiladze N, Turk AA, et al
    Intravascular lithotripsy compared to rotational atherectomy for the treatment of calcified distal left main coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2023;102:997-1003.
    PubMed     Abstract available


  112. UEDA H, Fujiwara Y, Nishida Y, Maenaka M, et al
    Impact of prolonged drug-coated balloon inflation on residual stenosis and clinical outcomes in coronary artery disease patients: A propensity score matched analysis.
    Catheter Cardiovasc Interv. 2023;102:969-978.
    PubMed     Abstract available


  113. JUN EJ, Hong SP, Kim B, Lee JB, et al
    Healing and stent coverage with the new ultrathin sirolimus-eluting stent with abluminal biodegradable polymer.
    Catheter Cardiovasc Interv. 2023;102:1040-1047.
    PubMed     Abstract available


  114. WALLNER K, Kearney KE, Tiwana J, Pristera N, et al
    Increased prescription dose for large vessel intravascular brachytherapy.
    Catheter Cardiovasc Interv. 2023;102:1034-1039.
    PubMed     Abstract available


  115. UNGUREANU C, Leone PP, Colletti G, Gasparini GL, et al
    Retrograde balloon hemostasis.
    Catheter Cardiovasc Interv. 2023;102:896-899.
    PubMed     Abstract available


  116. SHEKHAR S, Kaw R, Agrawal A, Isogai T, et al
    Outcomes of obesity in cardiogenic shock patients requiring mechanical circulatory support.
    Catheter Cardiovasc Interv. 2023;102:914-916.
    PubMed    


  117. FUJISAKI T, Kuno T, Iwagami M, Miyamoto Y, et al
    Net clinical benefit of dual antiplatelet therapy in elderly patients with acute coronary syndrome: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023;102:788-802.
    PubMed     Abstract available


  118. BLACHUTZIK F, Meier S, Weissner M, Schlattner S, et al
    Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.
    Catheter Cardiovasc Interv. 2023;102:823-833.
    PubMed     Abstract available


  119. GALASSI AR, Vadala G, Maniscalco L, Gasparini G, et al
    Wire-based antegrade dissection re-entry technique for coronary chronic total occlusions percutaneous revascularization: Experience from the ERCTO Registry.
    Catheter Cardiovasc Interv. 2023;102:864-877.
    PubMed     Abstract available


  120. REDDY RK, Foley M, Giannini F, Al-Lamee RK, et al
    Keeping it in the family: Use of the grandmother, mother, and child technique to navigate complex anatomy during Coronary sinus Reducer Implantation.
    Catheter Cardiovasc Interv. 2023;102:1057-1060.
    PubMed     Abstract available


  121. ICHIKAWA M, Matsuoka Y, Hasebe T
    Coronary arterial repair in patients with stable angina pectoris or acute coronary syndrome after ultrathin biodegradable polymer sirolimus-eluting stent implantation at 1-year follow-up by coronary angioscopy.
    Catheter Cardiovasc Interv. 2023;102:1012-1019.
    PubMed     Abstract available


  122. MERINOPOULOS I, Gunawardena T, Corballis N, Tsampasian V, et al
    Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
    Catheter Cardiovasc Interv. 2023;102:987-996.
    PubMed     Abstract available


    October 2023
  123. MOHAMED MO, Kinnaird T, Rab ST, Zaman S, et al
    Intracoronary imaging guided percutaneous coronary intervention outcomes among individuals with cardiogenic shock.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30859.
    PubMed     Abstract available


  124. CORTESE B, Kalkat H, Bathia G, Basavarajaiah S, et al
    The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30891.
    PubMed     Abstract available


  125. LU H, Hu Y, Ma Y, Zhou Y, et al
    Exploring indicators of success in chronic total occlusion percutaneous coronary intervention with Stingray system-based antegrade dissection re-entry: Insights from retrospective analysis.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30889.
    PubMed     Abstract available


  126. AL MAWED M, Vlachojannis M, Pula A, Gielen S, et al
    Delayed coronary perforation four days after percutaneous coronary intervention with subsequent cardiac tamponade: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30861.
    PubMed     Abstract available


  127. MITSUI K, Takagi K, Kakuta T, Noguchi T, et al
    Novel percutaneous intervention technique for obstructed coronary artery after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30865.
    PubMed     Abstract available


  128. PAOLUCCI L, De Micco F, Bezzeccheri A, Scarpelli M, et al
    Contrast media volume reduction with the DyeVert(TM) system to prevent acute kidney injury in stable patients undergoing coronary procedures.
    Catheter Cardiovasc Interv. 2023;102:655-662.
    PubMed     Abstract available


  129. HIRAI T
    "Crossing the invisible".
    Catheter Cardiovasc Interv. 2023;102:774-775.
    PubMed    


  130. KLEBER FX
    Commentary: Dissection still a sticking point in the widespread use of DCB in PCI.
    Catheter Cardiovasc Interv. 2023;102:772-773.
    PubMed    


    September 2023
  131. SINGH A, Donnino R, Small A, Bangalore S, et al
    Anomalous right coronary artery originating from the opposite sinus of Valsalva: Fractional flow reserve and intravascular ultrasound-guided management.
    Catheter Cardiovasc Interv. 2023 Sep 19. doi: 10.1002/ccd.30839.
    PubMed     Abstract available


  132. DI MAIO M, Esposito L, Silverio A, Bellino M, et al
    Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 13. doi: 10.1002/ccd.30842.
    PubMed     Abstract available


  133. ULLAH W, Sarvepalli D, Kumar A, Zahid S, et al
    Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30832.
    PubMed     Abstract available


  134. AHN J, Yu H, Rha SW, Choi BG, et al
    Long-term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30829.
    PubMed     Abstract available


  135. REMPAKOS A, Kostantinis S, Simsek B, Karacsonyi J, et al
    Impact of preprocedural anemia on in-hospital and follow-up outcomes of chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30810.
    PubMed     Abstract available


  136. HIRAI T, Grantham JA, Kandzari DE, Ballard W, et al
    Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30834.
    PubMed     Abstract available


  137. ALEXANDROU M, Rempakos A, Al Ogaili A, Choi JW, et al
    Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30830.
    PubMed     Abstract available


  138. SOMSEN YBO, de Winter RW, Giunta R, Schumacher SP, et al
    Collateral grading systems in retrograde percutaneous coronary intervention of chronic total occlusions.
    Catheter Cardiovasc Interv. 2023 Sep 6. doi: 10.1002/ccd.30812.
    PubMed     Abstract available


  139. BRUNO F, Kang J, Elia E, Han JK, et al
    Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30802.
    PubMed     Abstract available


  140. MIKLIN DJ, Garcia-Bengochea Y, Meraj P
    Acute coronary syndrome in an anomalous mid-LAD right coronary artery: Don't forget to look twice before turning left.
    Catheter Cardiovasc Interv. 2023;102:499-502.
    PubMed     Abstract available


  141. SCARPARO P, Schermers T, Improta R, Kardys I, et al
    Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms.
    Catheter Cardiovasc Interv. 2023;102:451-463.
    PubMed     Abstract available


  142. VAZQUEZ DJL, Lopez GA, Guzman MQ, Cancelo AV, et al
    Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Catheter Cardiovasc Interv. 2023;102:513-520.
    PubMed     Abstract available


  143. KIM SE, Choi KH, Song YB
    An unusual no-reflow phenomenon due to neointimal tissue embolization during drug eluting balloon intervention in stent restenosis: A case report.
    Catheter Cardiovasc Interv. 2023;102:481-485.
    PubMed     Abstract available


  144. SINGH N, Swamy AJ, Bajaj N, Gupta A, et al
    Management of a broken guiding catheter tip: Cut and fix technique.
    Catheter Cardiovasc Interv. 2023;102:495-498.
    PubMed     Abstract available


  145. DOOLUB G, Iannaccone M, Rab T, Routledge H, et al
    Sex-based treatment and outcomes for coronary bifurcation stenting: A report from the e-ULTIMASTER registry.
    Catheter Cardiovasc Interv. 2023;102:430-439.
    PubMed     Abstract available


  146. VELLA C, Preda A, Ferri L, Montorfano M, et al
    Intravascular coronary lithotripsy for the treatment of iatrogenic calcium embolization: The "block and crack" technique.
    Catheter Cardiovasc Interv. 2023;102:486-488.
    PubMed     Abstract available


    August 2023
  147. SIEBERT V, Goldstein J, Khan R, Lopez J, et al
    A goal-oriented hemodynamic approach to acute myocardial infarction complicated by cardiogenic shock-A single center experience.
    Catheter Cardiovasc Interv. 2023 Aug 7. doi: 10.1002/ccd.30792.
    PubMed     Abstract available


  148. SUZUKI N
    Prediction of residual ischemia after coronary stenting by quantitative flow ratio modulated by optical coherence tomography: Where we are now and our future perspectives.
    Catheter Cardiovasc Interv. 2023;102:392-393.
    PubMed    


  149. CHAUS A, Uretsky BF
    "CHIP-ping" away at the definition of PCI "complexity" and "risk".
    Catheter Cardiovasc Interv. 2023;102:396-397.
    PubMed    


  150. SHROFF GR, Garcia S, Schmidt C, Okeson B, et al
    Renal impairment and mortality in patients with STEMI and cardiogenic shock/cardiac arrest.
    Catheter Cardiovasc Interv. 2023;102:179-190.
    PubMed     Abstract available


  151. YASSIN I, Mosaad MA, Hassan AM, Abdelghani M, et al
    Fix and pull technique for retrieval of intracoronary unexpanded-stent entrapment.
    Catheter Cardiovasc Interv. 2023;102:247-248.
    PubMed     Abstract available


    July 2023
  152. KANDZARI DE, Garcia-Garcia HM, Stoler RC, Wang J, et al
    Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30783.
    PubMed     Abstract available


  153. GINETE WL, Groth NA, Rudeck MN, Renier CM, et al
    Outcomes of same-day discharge following percutaneous coronary intervention in a rural population.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30762.
    PubMed     Abstract available


  154. PARK DY, An S, Jolly N, Attanasio S, et al
    Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30784.
    PubMed     Abstract available


  155. PATLOLLA SH, Gilbert ON, Belford PM, Morris BN, et al
    Escalation strategies, management, and outcomes of acute myocardial infarction-cardiogenic shock patients receiving percutaneous left ventricular support.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30786.
    PubMed     Abstract available


  156. CARETTA G, Menozzi A
    Moderate aortic stenosis in patients with myocardial infarction: A guilty bystander?
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30766.
    PubMed    


  157. SONODA S, Node K
    Fighting calcification with optical coherence tomography-guided percutaneous coronary intervention. Commentary on the optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30776.
    PubMed    


  158. MAZNYCZKA A, Arunothayaraj S, Egred M, Banning A, et al
    Bifurcation left main stenting with or without intracoronary imaging: Outcomes from the EBC MAIN trial.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30785.
    PubMed     Abstract available


  159. KANE J, Kearney KE, Lombardi WL, Azzalini L, et al
    Electrocautery-assisted re-entry to resolve bilateral aorto-ostial chronic total occlusions due to leaflet obstruction following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30781.
    PubMed     Abstract available


  160. KARIMI GALOUGAHI K, Dakroub A, Chau K, Mathew R, et al
    Utility of optical coherence tomography in acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023;102:46-55.
    PubMed     Abstract available


  161. MITSUI K, Lee T, Miyazaki R, Hara N, et al
    Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Catheter Cardiovasc Interv. 2023;102:11-17.
    PubMed     Abstract available


  162. ZIEDSES DES PLANTES AC, Scoccia A, Neleman T, Groenland FTW, et al
    Optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023;102:25-35.
    PubMed     Abstract available


  163. STADER J, Antoniadis M, Ussat M, Wachter R, et al
    Comparison of quantitative flow ratio with instantaneous wave-free ratio and resting full-cycle ratio during daily routine in the catheterization laboratory.
    Catheter Cardiovasc Interv. 2023;102:91-100.
    PubMed     Abstract available


  164. PAREEK N, Frohmaier C, Smith M, Kordis P, et al
    A machine learning algorithm to predict a culprit lesion after out of hospital cardiac arrest.
    Catheter Cardiovasc Interv. 2023;102:80-90.
    PubMed     Abstract available


  165. WERNER GS, Lorenz S, Dimitriadis Z, Krueger B, et al
    Anemia and periprocedural complications determine contrast-associated acute kidney injury after recanalization of chronic coronary occlusions in chronic kidney disease.
    Catheter Cardiovasc Interv. 2023;102:101-110.
    PubMed     Abstract available


    June 2023
  166. GEWEHR DM, Carvalho PEP, Dagostin CS, Cardoso R, et al
    Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Jun 23. doi: 10.1002/ccd.30750.
    PubMed     Abstract available


  167. PICCOLO R, Leone A, Simonetti F, Avvedimento M, et al
    Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jun 19. doi: 10.1002/ccd.30749.
    PubMed     Abstract available


  168. MILEVA N, Ohashi H, Paolisso P, Leipsic J, et al
    Relationship between coronary volume, myocardial mass, and post-PCI fractional flow reserve.
    Catheter Cardiovasc Interv. 2023;101:1182-1192.
    PubMed     Abstract available


  169. PERSHAD A
    CTO revascularization in TAVR patients-The jury is still out.
    Catheter Cardiovasc Interv. 2023;101:1229.
    PubMed    


  170. ZONI CR, Mukherjee D, Gulati M
    Proposed new classification for acute coronary syndrome: Acute coronary syndrome requiring immediate reperfusion.
    Catheter Cardiovasc Interv. 2023;101:1177-1181.
    PubMed    


    May 2023
  171. GROENLAND FTW, Ziedses des Plantes AC, Neleman T, Scoccia A, et al
    Culprit lesion plaque characterization and thrombus grading by high-definition intravascular ultrasound in patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30699.
    PubMed     Abstract available


  172. DE FILIPPO O, Bruno F, Pinxterhuis TH, Gasior M, et al
    Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30696.
    PubMed     Abstract available


  173. RJOOB K, McGilligan V, McAllister R, Bond R, et al
    What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30684.
    PubMed     Abstract available


  174. OKSNES A, Skaar E, Engan B, Bleie O, et al
    Effectiveness, safety, and patient reported outcomes of a planned investment procedure in higher-risk chronic total occlusion percutaneous coronary intervention: Rationale and design of the invest-CTO study.
    Catheter Cardiovasc Interv. 2023 May 17. doi: 10.1002/ccd.30692.
    PubMed     Abstract available


  175. DING D, Tu S, Li Y, Li C, et al
    Quantitative flow ratio modulated by intracoronary optical coherence tomography for predicting physiological efficacy of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30681.
    PubMed     Abstract available


  176. GHETTI G, Bendandi F, Donati F, Ciurlanti L, et al
    Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30688.
    PubMed     Abstract available


  177. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30680.
    PubMed     Abstract available


  178. CALI F, Pagnesi M, Pezzola E, Montisci A, et al
    Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30682.
    PubMed     Abstract available


  179. ZHANG YJ, Ma WR, Xu B, Huang ZH, et al
    Retrograde percutaneous coronary intervention of chronic total occlusion via discontinuous septal channels.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30678.
    PubMed     Abstract available


  180. CADER A, Alasnag M
    Is there a woman paradox? Commentary on the Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 May 8. doi: 10.1002/ccd.30672.
    PubMed    


  181. ABRAHAM B, Farina JM, Fath A, Abdou M, et al
    The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2023 May 5. doi: 10.1002/ccd.30676.
    PubMed     Abstract available


  182. RIGATTIERI S, Casenghi M
    Lowering air kerma to improve the CTO operator's karma.
    Catheter Cardiovasc Interv. 2023;101:1172-1173.
    PubMed    


  183. FELDMAN D, Cao D, Sartori S, Zhang Z, et al
    Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2023;101:1134-1143.
    PubMed     Abstract available


  184. A PRADO GF, Blanco PJ, Bulant CA, Ares GD, et al
    Quantitative coronary three-dimensional geometry and its association with atherosclerotic disease burden and composition.
    Catheter Cardiovasc Interv. 2023;101:1036-1044.
    PubMed     Abstract available


  185. MORONI A, Marin F, Venturi G, Scarsini R, et al
    Management of failed stenting of the unprotected left main coronary artery.
    Catheter Cardiovasc Interv. 2023;101:1001-1013.
    PubMed     Abstract available


  186. MASSUSSI M, Adamo M, Rosati F, Chizzola G, et al
    Coronary artery disease and TAVI: Current evidence on a recurrent issue.
    Catheter Cardiovasc Interv. 2023;101:1154-1160.
    PubMed     Abstract available


  187. BUYUKGOZ C, Sandhu H, Shah S, Rower K, et al
    Strategies and techniques for percutaneous Veno-Arterial ECMO cannulation and decannulation in children.
    Catheter Cardiovasc Interv. 2023;101:1088-1097.
    PubMed     Abstract available


  188. MORETTI F, Rondi M, Ottani F
    Zero-contrast IVUS-guided complex PCI in a patient with NSTE-ACS and severe renal impairment.
    Catheter Cardiovasc Interv. 2023;101:1074-1080.
    PubMed     Abstract available


  189. SETO AH
    Cut, score, press, shock, or ablate?
    Catheter Cardiovasc Interv. 2023;101:975-977.
    PubMed    


  190. MUSUMECI G, Quadri G
    Bioresorbable scaffolds: Still alive in low-risk coronary artery disease.
    Catheter Cardiovasc Interv. 2023;101:973-974.
    PubMed    


  191. EL HAJJ M, Krajcer Z
    Bioresorbable stents: We have more work to do.
    Catheter Cardiovasc Interv. 2023;101:978-979.
    PubMed    


  192. WANG X, Li Y, Fu G, Xu B, et al
    Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials.
    Catheter Cardiovasc Interv. 2023;101:967-972.
    PubMed     Abstract available


    April 2023
  193. TARANTINI G, Cardaioli F
    Looking but not seeing the cap: The case for PROGRESS-CTO.
    Catheter Cardiovasc Interv. 2023;101:955-956.
    PubMed    


  194. GRINES CL, Tummala PE
    Calcified coronary nodule: Tip of the iceberg on a road full of thorns.
    Catheter Cardiovasc Interv. 2023;101:959-960.
    PubMed    


  195. YILDIZ M, Henry TD
    Unprotected left main occlusion: Rare but deadly.
    Catheter Cardiovasc Interv. 2023;101:953-954.
    PubMed    


  196. MUSUMECI G, Annibali G
    Keep it simple.
    Catheter Cardiovasc Interv. 2023;101:947-948.
    PubMed    


  197. BACCI E, Chiarito M, Sanz-Sanchez J, Leone PP, et al
    Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2023;101:911-917.
    PubMed     Abstract available


  198. HANNAN EL, Zhong Y, Cozzens K, Osinaga A, et al
    Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York.
    Catheter Cardiovasc Interv. 2023 Apr 1. doi: 10.1002/ccd.30648.
    PubMed     Abstract available


    March 2023
  199. TORABI AJ, Von der Lohe E, Kovacs RJ, Frick KA, et al
    Measures of social deprivation and outcomes after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30642.
    PubMed     Abstract available


  200. SIMSEK B, Khatri J, Young L, Kostantinis S, et al
    Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Mar 24. doi: 10.1002/ccd.30644.
    PubMed     Abstract available


  201. YUASA S, Lauri FM, Mejia-Renteria H, Liontou C, et al
    Angiography-derived functional assessment of left main coronary stenoses.
    Catheter Cardiovasc Interv. 2023 Mar 19. doi: 10.1002/ccd.30633.
    PubMed     Abstract available


  202. KIM YH, Her AY, Rha SW, Choi CU, et al
    Effects of delayed hospitalization on the 3-year clinical outcomes of patients with or without diabetes who had non-ST-segment-elevation myocardial infarction and underwent new-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30630.
    PubMed     Abstract available


  203. ALLANA SS, Brilakis ES
    What is the role of drug-coated balloons in chronic total occlusion percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30632.
    PubMed    


  204. AVRAN A, Zuffi A, Gobbi C, Gasperetti A, et al
    Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30616.
    PubMed     Abstract available


  205. POSTALIAN A, Krajcer Z
    The relationship between chronic kidney disease and "complex" percutaneous coronary intervention: Uncovering the details.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30612.
    PubMed    


  206. LEE A, Gilchrist IC
    A tale of two registries: Trends and outcomes of percutaneous coronary intervention in two transatlantic populations.
    Catheter Cardiovasc Interv. 2023 Mar 2. doi: 10.1002/ccd.30608.
    PubMed    


  207. SETO AH, Tehrani DM
    Better together? Maybe not with CTO-PCI.
    Catheter Cardiovasc Interv. 2023;101:828-829.
    PubMed    


  208. MANGIERI A, Nerla R, Castriota F, Reimers B, et al
    Cutting balloon to optimize predilation for stent implantation: The COPS randomized trial.
    Catheter Cardiovasc Interv. 2023;101:798-805.
    PubMed     Abstract available


  209. MATSUHIRO Y, Nakamura D, Dohi T, Ishihara T, et al
    Impact of calcified nodule on target lesion failure after stent implantation in hemodialysis patients.
    Catheter Cardiovasc Interv. 2023;101:701-712.
    PubMed     Abstract available


  210. TERASHITA K, Shimada Y, Yamanaka Y, Motohashi Y, et al
    Intraplaque wiring enables drug-coated balloons to be utilized for percutaneous recanalization of chronically occluded coronary arteries.
    Catheter Cardiovasc Interv. 2023;101:764-772.
    PubMed     Abstract available


  211. DURIG M, Arroyo D, Bedossa M, Commeau P, et al
    Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis.
    Catheter Cardiovasc Interv. 2023;101:679-686.
    PubMed     Abstract available


  212. MEGALY M, Gandolfo C, Zakhour S, Jiang M, et al
    Utilization of TandemHeart in cardiogenic shock: Insights from the THEME registry.
    Catheter Cardiovasc Interv. 2023;101:756-763.
    PubMed     Abstract available


  213. ANDREASEN LN, Balleby IR, Barkholt TO, Hebsgaard L, et al
    Early healing after treatment of coronary lesions by thin strut everolimus, or thicker strut biolimus eluting bioabsorbable polymer stents: The SORT-OUT VIII OCT study.
    Catheter Cardiovasc Interv. 2023;101:787-797.
    PubMed     Abstract available


    February 2023
  214. UENO K, Morita N, Kojima Y, Takahashi H, et al
    Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Feb 25. doi: 10.1002/ccd.30598.
    PubMed     Abstract available


  215. IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
    Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized t
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30600.
    PubMed     Abstract available


  216. HEATON J, Singh S, Nanavaty D, Okoh AK, et al
    Impact of frailty on outcomes in acute ST-elevated myocardial infarctions undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30595.
    PubMed     Abstract available


  217. WILL M, Schwarz K, Weiss T, Leibundgut G, et al
    The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30601.
    PubMed     Abstract available


  218. NISHI T, Kume T, Yamada R, Koto S, et al
    Efficacy of a new generation intracoronary optical coherence tomography imaging system with fast pullback.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30573.
    PubMed     Abstract available


  219. REMPAKOS A, Simsek B, Kostantinis S, Karacsonyi J, et al
    Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30581.
    PubMed     Abstract available


  220. KOSTANTINIS S, Simsek B, Karacsonyi J, Rempakos A, et al
    Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30580.
    PubMed     Abstract available


  221. LEE KT, Taliotis D, Hamilton M, Manghat N, et al
    Transcatheter closure of large postinfarct ventricular septal defect: Initial results of prototype Occlutech(R) device including the first-in-human.
    Catheter Cardiovasc Interv. 2023;101:620-627.
    PubMed     Abstract available


  222. SERRAO G, Dangas G
    SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock-2 Registry.
    Catheter Cardiovasc Interv. 2023;101:676.
    PubMed    


  223. TARANTINI G, Cardaioli F
    High bleeding risk patients.
    Catheter Cardiovasc Interv. 2023;101:677-678.
    PubMed    


  224. ARUNOTHAYARAJ S, Lassen JF, Clesham GJ, Spence MS, et al
    Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial.
    Catheter Cardiovasc Interv. 2023;101:553-562.
    PubMed     Abstract available


  225. VERA-VERA S, Jurado-Roman A, Moreno R, Galeote G, et al
    Percutaneous treatment of multiple fistulas associated with a giant aneurysm.
    Catheter Cardiovasc Interv. 2023;101:651-654.
    PubMed     Abstract available


  226. AZZALINI L, Hirai T, Salisbury A, Gosch K, et al
    Validation of the new PROGRESS-CTO complication risk scores in the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2023;101:536-542.
    PubMed     Abstract available


  227. VAN HEMERT ND, Voskuil M, Rozemeijer R, Kraaijeveld AO, et al
    Long-term follow-up of contemporary drug-eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial.
    Catheter Cardiovasc Interv. 2023;101:505-510.
    PubMed     Abstract available


  228. NAGOSHI R, Kijima Y, Kozuki A, Fujiwara R, et al
    Success rate and influencing factors of a balloon-push technique: A new technique to remove side branch-jailed struts under three-dimensional optical coherence tomography guidance.
    Catheter Cardiovasc Interv. 2023;101:528-535.
    PubMed     Abstract available


    January 2023
  229. KARACSONYI J, Alaswad K, Krestyaninov O, Karmpaliotis D, et al
    Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Jan 25. doi: 10.1002/ccd.30564.
    PubMed     Abstract available


  230. KAWAMURA Y, Yoshimachi F, Kasai S, Ikari Y, et al
    Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30568.
    PubMed     Abstract available


  231. CHEN H, Spirito A, Sartori S, Nicolas J, et al
    Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30569.
    PubMed     Abstract available


  232. RASANEN A, Karkkainen JM, Eranti A, Eranen J, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30558.
    PubMed     Abstract available


  233. AZZALINI L, Boudou N, Avran A, Kane J, et al
    Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30565.
    PubMed     Abstract available


  234. MONTARELLO NJ, Quagliana A, Sondergaard L, De Backer O, et al
    Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2023 Jan 18. doi: 10.1002/ccd.30561.
    PubMed     Abstract available


  235. PATLOLLA SH, Truesdell AG, Basir MB, Rab ST, et al
    No "July Effect" in the management and outcomes of acute myocardial infarction: An 18-year United States national study.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30553.
    PubMed     Abstract available


  236. DAVIS MG, Blankenship JC
    PCI for late STEMI: Better late than never?
    Catheter Cardiovasc Interv. 2023;101:11-12.
    PubMed    


  237. CHAUS A, Uretsky BF
    Bifurcation stenting: If the shoe doesn't fit.
    Catheter Cardiovasc Interv. 2023;101:58-59.
    PubMed    


  238. IKEDA K, Kobayashi M, Chikamori T, Yanaka Y, et al
    Comparison between the diagnostic performance of vessel fractional flow reserve and nonhyperemic pressure ratio for functionally significant coronary stenosis severity as assessed by fractional flow reserve.
    Catheter Cardiovasc Interv. 2023;101:72-78.
    PubMed     Abstract available


  239. PETKOSKA D, Zafirovska B, Vasilev I, Novotni G, et al
    Radial and ulnar approach for carotid artery stenting with Roadsaver double layer micromesh stent: Early and long-term follow-up.
    Catheter Cardiovasc Interv. 2023;101:154-163.
    PubMed     Abstract available


  240. DOOST A, Chilmeran A, Gomes A, Dworakowski R, et al
    Single arterial access closure of post-infarction ventricular septal defect: A case series.
    Catheter Cardiovasc Interv. 2023;101:209-216.
    PubMed     Abstract available


  241. GRIFFIN ACG, Yildiz M, Bradley S, Smith JE, et al
    Frequency and outcomes of STEMI patients presenting between 12 and 24 h after symptom onset: Late-presenting STEMI.
    Catheter Cardiovasc Interv. 2023;101:1-10.
    PubMed     Abstract available


  242. HADDAD RN, Adel Hassan A, Al Soufi M, Kasem M, et al
    A word of caution: Early failure of Magmaris(R) bioresorbable stent after pulmonary artery stenting.
    Catheter Cardiovasc Interv. 2023;101:131-134.
    PubMed     Abstract available


  243. PRICE J, Okyere R, Al-Kindi S, Gupta A, et al
    Management of a right coronary artery mycotic coronary aneurysm with percutaneous intervention with covered stents.
    Catheter Cardiovasc Interv. 2023;101:108-112.
    PubMed     Abstract available


  244. BINGEN BO, Al Amri I, Montero-Cabezas JM, van der Kley F, et al
    Bail out lithotripsy to treat delayed valve-in-valve TAVR-related coronary obstruction.
    Catheter Cardiovasc Interv. 2023;101:97-101.
    PubMed     Abstract available


  245. SCHOTT JP, Rusia A, Lynch S, Tawney A, et al
    Risk factors for percutaneous left ventricular assist device explant complications.
    Catheter Cardiovasc Interv. 2023;101:147-153.
    PubMed     Abstract available


  246. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
    Catheter Cardiovasc Interv. 2023;101:13-21.
    PubMed     Abstract available


  247. NOSAIR W, Araj FG
    Mechanical circulatory support for cardiogenic shock complicating spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2023;101:121.
    PubMed    


  248. GAROT P, Brunel P, Dibie A, Morelle JF, et al
    Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study.
    Catheter Cardiovasc Interv. 2023;101:60-71.
    PubMed     Abstract available


  249. MORICI N, Frea S, Bertaina M, Sacco A, et al
    SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock-2 registry.
    Catheter Cardiovasc Interv. 2023;101:22-32.
    PubMed     Abstract available


  250. ACHIM A, Krivoshei L, Leibundgut G
    Unrecoverable stent deformation in the left main: Crush it or remove it?
    Catheter Cardiovasc Interv. 2023;101:113-120.
    PubMed     Abstract available


    December 2022
  251. QIAN J, Wu Y, Li C, Yin J, et al
    Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
    Catheter Cardiovasc Interv. 2022 Dec 8. doi: 10.1002/ccd.30472.
    PubMed     Abstract available


  252. KALETA FP, Gilchrist IC
    Coronary angiography after resuscitation without ST-Elevation: Indication remains elusive.
    Catheter Cardiovasc Interv. 2022;100:1171-1172.
    PubMed    


  253. TEHRANI DM, Seto AH
    The future of angiography: Estimates of FFR pre- and post-PCI.
    Catheter Cardiovasc Interv. 2022;100:1218-1219.
    PubMed    


  254. KERN MJ
    Age and the cascade impact on coronary flow reserve (CFR) and discordance of fractional flow reserve and non-hyperemic pressure ratios (NHPR).
    Catheter Cardiovasc Interv. 2022;100:1206-1207.
    PubMed    


  255. FARIA D, Mejia-Renteria H, Lee JM, Lee SH, et al
    Age-related changes in the coronary microcirculation influencing the diagnostic performance of invasive pressure-based indices and long-term patient prognosis.
    Catheter Cardiovasc Interv. 2022;100:1195-1205.
    PubMed     Abstract available


  256. THALER C, Witt DR, Henry TD, Grey EZ, et al
    Revascularization and long-term outcomes in high-acuity spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2022;100:1229-1241.
    PubMed     Abstract available


    November 2022
  257. NG JCK, Ang H, Zhong L, Hakim D, et al
    Multimodality imaging results of TAP versus novel modified TAP stenting in coronary bifurcation: From bench testing to first-in-man investigation.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30496.
    PubMed     Abstract available


  258. AZZALINI L, Moroni F, Dawson KL, Kearney KE, et al
    Chronic total occlusion percutaneous coronary intervention in heart transplant patients.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30476.
    PubMed     Abstract available


  259. NAGRAJ S, Tzoumas A, Kakargias F, Giannopoulos S, et al
    Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients.
    Catheter Cardiovasc Interv. 2022 Nov 6. doi: 10.1002/ccd.30446.
    PubMed     Abstract available


  260. SELVARAJ V, Chatterjee S, Hirai T, Abbott JD, et al
    Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2022 Nov 3. doi: 10.1002/ccd.30467.
    PubMed     Abstract available


  261. SCOCCIA A, Scarparo P, Neleman T, Kakar H, et al
    Diagnostic accuracy of angiography-based vessel fractional flow reserve after chronic coronary total occlusion recanalization.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30439.
    PubMed     Abstract available


  262. LEE HJ, Mejia-Renteria H, Escaned J, Doh JH, et al
    Prediction of functional results of percutaneous coronary interventions with virtual stenting and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30451.
    PubMed     Abstract available


  263. TARANTINI G, Cardaioli F
    CHIP-PCI: Ready for a prime time?
    Catheter Cardiovasc Interv. 2022;100:721-722.
    PubMed    


  264. ALLANA SS, Brilakis ES
    How good is intravascular brachytherapy for treating in-stent restenosis?
    Catheter Cardiovasc Interv. 2022;100:763-764.
    PubMed    


  265. COLOPI M, Musumeci G
    Intravascular lithotripsy pretreatment of coronary chronic total occlusions: Current PROGRESS and the Next Frontier.
    Catheter Cardiovasc Interv. 2022;100:939-940.
    PubMed    


  266. WINSCOTT JG, Hillegass WB
    Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure.
    Catheter Cardiovasc Interv. 2022;100:747-748.
    PubMed    


  267. ALLANA SS, Brilakis ES
    Dual guidewire balloon for antegrade fenestration re-entry: A welcome addition to the CTO operators' armamentarium.
    Catheter Cardiovasc Interv. 2022;100:933-935.
    PubMed    


  268. JONES EL, Blankenship JC
    Women deserve the best care.
    Catheter Cardiovasc Interv. 2022;100:936-937.
    PubMed    


  269. SIMSEK B, Kostantinis S, Karacsonyi J, Allana S, et al
    Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;100:749-755.
    PubMed     Abstract available


  270. WALLNER K, Kearney KE, Kim M, Tiwana J, et al
    Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.
    Catheter Cardiovasc Interv. 2022;100:759-762.
    PubMed     Abstract available


  271. CHAMI T, Mahowald MK, Brilakis E
    Retrograde approach for rewiring a jailed side branch during double kissing crush stenting.
    Catheter Cardiovasc Interv. 2022;100:756-758.
    PubMed     Abstract available


  272. KERN MJ, Cox D, Fearon W, Johnson N, et al
    Is FFR dead? A conversation in cardiology.
    Catheter Cardiovasc Interv. 2022;100:1045-1050.
    PubMed    


  273. NAGASAKA T, Amanai S, Ishibashi Y, Aihara K, et al
    Long-term outcomes of intermediate coronary stenosis in patients undergoing hemodialysis after deferred revascularization based on fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;100:971-978.
    PubMed     Abstract available


  274. ALLALI A, Toelg R, Abdel-Wahab M, Hemetsberger R, et al
    Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: The PREPARE-CALC-COMBO study.
    Catheter Cardiovasc Interv. 2022;100:979-989.
    PubMed     Abstract available


  275. GILLMORE T, Jung RG, Moreland R, Di Santo P, et al
    Impact of intracoronary assessments on revascularization decisions: A contemporary evaluation.
    Catheter Cardiovasc Interv. 2022;100:955-963.
    PubMed     Abstract available


  276. MASUDA H, Kuramitsu S, Ito T, Morofuji T, et al
    Outcomes of paclitaxel-coated balloon angioplasty for in-stent calcified nodule: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2022;100:990-999.
    PubMed     Abstract available


  277. ROLA P, Wlodarczak S, Doroszko A, Lesiak M, et al
    The bioresorbable magnesium scaffold (Magmaris)-State of the art: From basic concept to clinical application.
    Catheter Cardiovasc Interv. 2022;100:1051-1058.
    PubMed     Abstract available


  278. DEL VAL D, Cuesta J, Roquero P, Alfonso F, et al
    Lithotripsy for calcified in-stent restenosis. The "rock strata peeling pattern": A novel fracture pattern detected by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;100:1036-1038.
    PubMed     Abstract available


  279. PARFREY S, Mozid A
    Feasibility of facilitated antegrade dissection with Stingray-based re-entry for coronary chronic total occlusions with previously stented graft-to-native-vessel anastomoses.
    Catheter Cardiovasc Interv. 2022;100:1030-1035.
    PubMed     Abstract available


  280. MORETTI F, Bernelli C, Pellegrini D, Boccuzzi G, et al
    Determinants and long-term outcomes of largely uncovered struts in thin-struts drug-eluting stents assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S25-S35.
    PubMed     Abstract available


  281. BUCCOLA J, Meinen J, Spinelli J, Hammerstone M, et al
    Investigating real-world impact of optical coherence tomography workflow-guided coronary interventions: Design and rationale of the LightLab Clinical Initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S1-S6.
    PubMed     Abstract available


  282. SHLOFMITZ E, Croce K, Bezerra H, Sheth T, et al
    The MLD MAX OCT algorithm: An imaging-based workflow for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S7-S13.
    PubMed     Abstract available


  283. RAJA A, Osborn EA, Bergmark BA, Croce KD, et al
    OCT utilization: Summary statistics from the LightLab clinical initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S36-S43.
    PubMed     Abstract available


  284. KHUDDUS MA, Darki A, Padaliya BB, West NEJ, et al
    Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S14-S24.
    PubMed     Abstract available


    October 2022
  285. ANZAI F, Yoshihisa A, Takeishi R, Hotsuki Y, et al
    Acute myocardial infarction caused by Kawasaki disease requires more intensive therapy: Insights from the Japanese registry of All Cardiac and Vascular Diseases-Diagnosis Procedure combination.
    Catheter Cardiovasc Interv. 2022 Oct 31. doi: 10.1002/ccd.30457.
    PubMed     Abstract available


  286. WATANABE Y, Sakakura K, Taniguchi Y, Yamamoto K, et al
    Impact of intravascular ultrasound-incomplete stent apposition on stent failure.
    Catheter Cardiovasc Interv. 2022 Oct 27. doi: 10.1002/ccd.30424.
    PubMed     Abstract available


  287. NAIMI I, Morray B, Portman MA, Steinberg ZL, et al
    Use of the PK Papyrus covered coronary stent in the treatment of Kawasaki disease-associated giant coronary artery aneurysms.
    Catheter Cardiovasc Interv. 2022 Oct 26. doi: 10.1002/ccd.30458.
    PubMed     Abstract available


  288. KOSTANTINIS S, Simsek B, Karacsonyi J, Alaswad K, et al
    Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Oct 25. doi: 10.1002/ccd.30425.
    PubMed     Abstract available


  289. CORTESE B, Piraino D, Gentile D, Onea HL, et al
    Intravascular imaging for left main stem assessment: An update on the most recent clinical data.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30440.
    PubMed     Abstract available


  290. GRINES CL, Tummala P
    Will the TRANSFORM II trial transform our management of small vessel coronary disease?
    Catheter Cardiovasc Interv. 2022 Oct 18. doi: 10.1002/ccd.30429.
    PubMed    


  291. SIDDIQI TJ, Khan MS, Karimi Galougahi K, Shlofmitz E, et al
    Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Oct 17. doi: 10.1002/ccd.30416.
    PubMed     Abstract available


  292. MATHEWS SJ, Brown CL, Kolski BC, Marques VM, et al
    Initial experience with a continuous mechanical aspiration system for thrombus removal before percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30389.
    PubMed     Abstract available


  293. OSMAN M, Syed M, Simpson TF, Bhardwaj B, et al
    Incidence and outcomes of cardiogenic shock among women with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2022;100:530-534.
    PubMed     Abstract available


  294. GRECO A, Sciahbasi A, Abizaid A, Mehran R, et al
    Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
    Catheter Cardiovasc Interv. 2022;100:544-552.
    PubMed     Abstract available


  295. WANG HY, Mo R, Guan CD, Wang Y, et al
    Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;100:593-595.
    PubMed    


  296. CHAMBERS JW, Martinsen BJ, Sturm RC, Mandair D, et al
    Orbital atherectomy of calcified coronary ostial lesions.
    Catheter Cardiovasc Interv. 2022;100:553-559.
    PubMed     Abstract available


  297. WILGENHOF A, Vescovo GM, Bezzeccheri A, Scott B, et al
    Minimalistic hybrid approach for the percutaneous treatment of chronic coronary total occlusions: An in-depth analysis of the whole algorithm.
    Catheter Cardiovasc Interv. 2022;100:502-511.
    PubMed     Abstract available


    September 2022
  298. ELKARYONI A, Cohen DJ, Lopez JJ, Huded CP, et al
    Trends in invasive treatment of patients hospitalized with aortic stenosis complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30413.
    PubMed     Abstract available


  299. MEGALY M, Buda K, Karacsonyi J, Kostantinis S, et al
    Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30403.
    PubMed     Abstract available


  300. BASHAR H, Matetic A, Curzen N, Mamas MA, et al
    Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 21. doi: 10.1002/ccd.30404.
    PubMed     Abstract available


  301. CARANDE EJ, Protty MB, Verhemel S, Hussein MH, et al
    Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.
    Catheter Cardiovasc Interv. 2022 Sep 14. doi: 10.1002/ccd.30400.
    PubMed     Abstract available


  302. AHLERS MJ, Srivastava PK, Basir MB, O'Neill WW, et al
    Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30390.
    PubMed     Abstract available


  303. SHAMKHANI W, Rashid M, Mamas M
    Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.
    Catheter Cardiovasc Interv. 2022 Sep 2. doi: 10.1002/ccd.30366.
    PubMed     Abstract available


  304. SETO AH, Long VJ
    Should doctors replace machines in prehospital electrocardiogram interpretation?
    Catheter Cardiovasc Interv. 2022;100:304-305.
    PubMed    


  305. MUSUMECI G, Civera S
    When not to treat could be the best option.
    Catheter Cardiovasc Interv. 2022;100:338-339.
    PubMed     Abstract available


  306. BUTMAN SM
    Variability in healthcare delivery: It is never a good thing.
    Catheter Cardiovasc Interv. 2022;100:317-318.
    PubMed     Abstract available


  307. VON LEWINSKI D, Herold L, Stoffel C, Patzold S, et al
    PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.
    Catheter Cardiovasc Interv. 2022;100:319-327.
    PubMed     Abstract available


  308. ALTSTIDL JM, Achenbach S, Marwan M, Trobs M, et al
    Comparison of adenosine-independent pressure indices to fractional flow reserve in stent-jailed bifurcation side branches.
    Catheter Cardiovasc Interv. 2022;100:369-377.
    PubMed     Abstract available


  309. HONDA Y, Yamawaki M, Mori S, Tsutsumi M, et al
    Predictive performance of J-Calc-CTO score for guidewire crossing through chronic total occlusion lesions within 30 minutes: J-CTO score modified by computed tomography coronary angiography.
    Catheter Cardiovasc Interv. 2022 Sep 1. doi: 10.1002/ccd.30384.
    PubMed     Abstract available


    August 2022
  310. XIE J, Huang J, Tong G, Yang J, et al
    A comment and suggestion on angiography-derived FFR: NiFFR.
    Catheter Cardiovasc Interv. 2022 Aug 21. doi: 10.1002/ccd.30361.
    PubMed    


  311. SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
    Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
    PubMed     Abstract available


  312. KOSTANTINIS S, Simsek B, Karacsonyi J, Davies RE, et al
    Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30354.
    PubMed     Abstract available


  313. DI MARIO C, Kucukseymen S
    Second generation drug eluting stent: The longer, the better?
    Catheter Cardiovasc Interv. 2022;100:188-189.
    PubMed    


  314. GUO J, Ning Y, Wu S, Zhang F, et al
    Risk factors for in-stent restenosis after vertebral artery stenting of V1 segment: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022;100:279-289.
    PubMed     Abstract available


  315. MENNUNI MG, Solli M, Galiffa V, Patti G, et al
    Unmasking of a significant left main stenosis in a patient with high left ventricular pressures.
    Catheter Cardiovasc Interv. 2022;100:216-218.
    PubMed     Abstract available


  316. GAUTIER A, Hovasse T, Arroyo D, Unterseeh T, et al
    Safety and efficacy of 48 mm Xience Xpedition everolimus-eluting stent for the treatment of long coronary lesions.
    Catheter Cardiovasc Interv. 2022;100:179-187.
    PubMed     Abstract available


    July 2022
  317. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Antegrade dissection and re-entry versus parallel wiring in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30346.
    PubMed     Abstract available


  318. MUSTO C, Scappaticci M, Biondi-Zoccai G, De Felice F, et al
    Instantaneous wave-free ratio-guided revascularization of nonculprit lesions in STEMI patients with multivessel coronary disease: The WAVE registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30342.
    PubMed     Abstract available


  319. SIMSEK B, Gorgulu S, Kostantinis S, Karacsonyi J, et al
    Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30347.
    PubMed     Abstract available


  320. TRIANTAFYLLIS AS, van Nunen LX, Lesizza P, Pagourelias ED, et al
    Angiographic predictors of aberrant circumflex artery during cardiac catheterization.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30322.
    PubMed     Abstract available


  321. GALASSI AR, Vadala G, Testa G, Puglisi S, et al
    Dual guidewire balloon antegrade fenestration and re-entry technique for coronary chronic total occlusions percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30324.
    PubMed     Abstract available


  322. NELEMAN T, Khachabi J, Jonker H, Rademaker-Havinga T, et al
    Validation of a simplified intravascular ultrasound core lab analysis method in stented coronary arteries.
    Catheter Cardiovasc Interv. 2022 Jul 10. doi: 10.1002/ccd.30321.
    PubMed     Abstract available


  323. OKUYA Y, Gohil K, Moussa ID
    Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jul 5. doi: 10.1002/ccd.30304.
    PubMed     Abstract available


  324. SHELDON M, Blankenship JC
    STEMI in nonagenarians: Never too old.
    Catheter Cardiovasc Interv. 2022;100:17-18.
    PubMed    


  325. ASHLEY KE, Hillegass WB
    Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;100:83-84.
    PubMed    


  326. DI SERAFINO L, Esposito G
    May FFR-guided PCI save lives?: Commentary on: "Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry".
    Catheter Cardiovasc Interv. 2022;100:49-50.
    PubMed    


  327. KALYANASUNDARAM A, Seth A
    Retrograde CTO PCI-the final frontier-challenges and outcomes.
    Catheter Cardiovasc Interv. 2022;100:28-29.
    PubMed    


  328. GRINES CL, Marshall JJ
    Directional coronary atherectomy revisited.
    Catheter Cardiovasc Interv. 2022;100:59-60.
    PubMed    


  329. ADJEDJ J, Morelle JF, Saint Etienne C, Fichaux O, et al
    Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry.
    Catheter Cardiovasc Interv. 2022;100:40-48.
    PubMed     Abstract available


  330. KUMAR K, Coonse K, Zakhary B, Cigarroa JE, et al
    Novel method for left ventricular unloading utilizing percutaneous pulmonary artery drainage in cardiorespiratory failure due to COVID-19 infection.
    Catheter Cardiovasc Interv. 2022;100:175-178.
    PubMed     Abstract available


  331. HIRSCH K, Yogeswaran V, Dean LS
    Spontaneous coronary artery dissection and exogenous estrogen in a transgender female.
    Catheter Cardiovasc Interv. 2022;100:96-99.
    PubMed     Abstract available


  332. LIANG B, Gu N
    High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
    Catheter Cardiovasc Interv. 2022;100:61-71.
    PubMed     Abstract available


  333. FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
    Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
    PubMed     Abstract available


    June 2022
  334. FAOUR A, Cherrett C, Gibbs O, Lintern K, et al
    Utility of prehospital electrocardiogram interpretation in ST-segment elevation myocardial infarction utilizing computer interpretation and transmission for interventional cardiologist consultation.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30300.
    PubMed     Abstract available


  335. RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
    Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
    PubMed     Abstract available


  336. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    PubMed     Abstract available


  337. THAKKER R, Jneid H
    Sex-related differences in cardiogenic shock: Can we do better in women?
    Catheter Cardiovasc Interv. 2022;99:1996-1997.
    PubMed    


  338. GRINES CL, Kern MJ
    Should we use invasive fractional flow reserve (FFR), imaging, or both to determine the significance of a "borderline" lesion?
    Catheter Cardiovasc Interv. 2022;99:2016-2017.
    PubMed    


  339. SIMSEK B, Brilakis ES
    Why double-kissing crush should be preferred over culotte for two-stent bifurcation stenting.
    Catheter Cardiovasc Interv. 2022;99:2006-2007.
    PubMed    


  340. KARACSONYI J, Brilakis ES, Chandwaney RH
    Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2022;99:2038-2042.
    PubMed     Abstract available


  341. OSMAN M, Syed M, Kheiri B, Bianco C, et al
    Age stratified sex-related differences in incidence, management, and outcomes of cardiogenic shock.
    Catheter Cardiovasc Interv. 2022;99:1984-1995.
    PubMed     Abstract available


  342. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
    Catheter Cardiovasc Interv. 2022;99:1965-1975.
    PubMed     Abstract available


  343. KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
    Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
    PubMed     Abstract available


    May 2022
  344. KLEIN LW, Anderson HV, Cigarroa J
    Integrating shared decision-making in coronary revascularization with quality assurance programs.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30222.
    PubMed    


  345. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
    PubMed     Abstract available


  346. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
    Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
    PubMed     Abstract available


  347. ISMAYL M, Machanahalli Balakrishna A, Walters RW, Pajjuru VS, et al
    In-hospital mortality and readmission after ST-elevation myocardial infarction in nonagenarians: A nationwide analysis from the United States.
    Catheter Cardiovasc Interv. 2022 May 14. doi: 10.1002/ccd.30227.
    PubMed     Abstract available


  348. ONO M, Onuma Y, Kawashima H, Hara H, et al
    Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
    PubMed     Abstract available


  349. JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
    Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
    PubMed     Abstract available


  350. MA W, Wang Q, Wang B, Wang C, et al
    Novel predictors of stent under-expansion regarding calcified coronary lesions assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1473-1481.
    PubMed     Abstract available


  351. WANG M, Liu H, Xu B, Bian X, et al
    Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
    PubMed     Abstract available


  352. HE J, Zhang D, Zhang R, Wang H, et al
    Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system in unprotected left main bifurcation.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1465-1472.
    PubMed     Abstract available


  353. GUAN C, Geng L, Zhang R, You J, et al
    Long-term prognostic value of dynamic function assessment of intermediate coronary lesion with computational physiology.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1386-1394.
    PubMed     Abstract available


  354. PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
    Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1741-1749.
    PubMed     Abstract available


  355. BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
    Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
    Catheter Cardiovasc Interv. 2022;99:1752-1757.
    PubMed     Abstract available


    April 2022
  356. SALEM H, Mintz GS, Matsumura M, Zhang M, et al
    Reasons for lesion uncrossability as assessed by intravascular ultrasound.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
    PubMed     Abstract available


  357. BALDETTI L, Beneduce A, Boccellino A, Pagnesi M, et al
    Bedside intra-aortic balloon pump insertion in cardiac intensive care unit: A single-center experience.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30197.
    PubMed     Abstract available


  358. PIRIOU PG, Manigold T, Letocart V, Le Ruz R, et al
    Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30194.
    PubMed     Abstract available


  359. FERNANDEZ-PEREGRINA E, Ahmad H, Mintz GS, Garcia-Garcia HM, et al
    When coronary imaging and physiology are discordant, how best to manage coronary lesions? An appraisal of the clinical evidence.
    Catheter Cardiovasc Interv. 2022 Apr 4. doi: 10.1002/ccd.30186.
    PubMed     Abstract available


  360. FABRIS E, Menzio S, Gregorio C, Pezzato A, et al
    Effect of prehospital treatment in STEMI patients undergoing primary PCI.
    Catheter Cardiovasc Interv. 2022;99:1500-1508.
    PubMed     Abstract available


  361. LEMOR A, Dabbagh MF, Cohen D, Villablanca P, et al
    Rates and impact of vascular complications in mechanical circulatory support.
    Catheter Cardiovasc Interv. 2022;99:1702-1711.
    PubMed     Abstract available


  362. RIVERO F, Marco V, Biccire FG, Budassi S, et al
    The double injection technique to improve visualization of severe coronary lesions with optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99:1511-1517.
    PubMed     Abstract available


  363. SONCK J, Mizukami T, Johnson NP, Nagumo S, et al
    Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks.
    Catheter Cardiovasc Interv. 2022;99:1518-1525.
    PubMed     Abstract available


  364. KHOKHAR AA, Zelias A, Zlahoda-Huzior A, Dudek D, et al
    Complication during robotic-PCI: Iatrogenic guiding catheter dissection.
    Catheter Cardiovasc Interv. 2022;99:1526-1528.
    PubMed     Abstract available


  365. BANSAL A, Jaber WA, Reed GW, Puri R, et al
    Surgical versus medical management of infective endocarditis after TAVR.
    Catheter Cardiovasc Interv. 2022;99:1592-1596.
    PubMed     Abstract available


    March 2022
  366. JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
    Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
    Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
    PubMed     Abstract available


  367. TONOMURA D, Shimada Y, Yamanaka Y, Terashita K, et al
    Laser vaporization of atherothrombotic burden before drug-coated balloon application in ST-segment elevation myocardial infarction: Two-year outcomes of the laser-DCB trial.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30149.
    PubMed     Abstract available


  368. VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
    Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
    PubMed     Abstract available


  369. PARIKH PB, Reilly JP
    Outcomes with early opioid administration in acute coronary syndromes: Does sex matter?
    Catheter Cardiovasc Interv. 2022;99:996-997.
    PubMed    


  370. TARANTINI G, Cardaioli F
    Bioresorbable scaffolds: zebras are not striped horses.
    Catheter Cardiovasc Interv. 2022;99:1084-1085.
    PubMed    


  371. PATEL NJ, Heuser RR
    Physiologic liquid plumber: A novel treatment to facilitate crossing of chronic total occlusions.
    Catheter Cardiovasc Interv. 2022;99:1074.
    PubMed    


  372. GRINES CL, Marshall JJ
    Step back to see the complete picture: Complete versus incomplete revascularization of multivessel coronary disease.
    Catheter Cardiovasc Interv. 2022;99:968-969.
    PubMed    


  373. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    PubMed    


  374. SPIRITO A, Mehran R
    Elderly patients with acute myocardial infarction: Targeted or complete revascularization?
    Catheter Cardiovasc Interv. 2022;99:979-980.
    PubMed    


  375. DANGAS G, Garg A
    Double kissing crush stenting: No pain, no gain?
    Catheter Cardiovasc Interv. 2022;99:1045-1046.
    PubMed    


  376. SIMSEK B, Kostantinis S, Karacsonyi J, Vemmou E, et al
    Challenges and outcomes of the double kissing crush stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;99:1038-1044.
    PubMed     Abstract available


  377. BISCAGLIA S, Erriquez A, Serenelli M, D'Ascenzo F, et al
    Complete versus culprit-only strategy in older MI patients with multivessel disease.
    Catheter Cardiovasc Interv. 2022;99:970-978.
    PubMed     Abstract available


  378. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    PubMed     Abstract available


  379. HILLERSON D, Whiteside HL, Dugan AJ, Coots RD, et al
    Predicting mortality in nonsurgical patients before cannulation for veno-arterial extracorporeal life support: Development and validation of the LACT-8 score.
    Catheter Cardiovasc Interv. 2022;99:1115-1124.
    PubMed     Abstract available


  380. TAKAHASHI T, Nishi T, Zimmermann FM, Granada JF, et al
    Clinical validation of a novel simplified offline tool for SYNTAX score calculation.
    Catheter Cardiovasc Interv. 2022;99:1366-1368.
    PubMed    


  381. GRAHAM JJ, Bagai A, Wijeysundera H, Weisz G, et al
    Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trial.
    Catheter Cardiovasc Interv. 2022;99:1065-1073.
    PubMed     Abstract available


  382. JENTZER JC, Soussi S, Lawler PR, Kennedy JN, et al
    Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population.
    Catheter Cardiovasc Interv. 2022;99:1006-1014.
    PubMed     Abstract available


  383. MEJIA-RENTERIA H, Faria D, Lee JM, Lee SH, et al
    Association between patient age, microcirculation, and coronary stenosis assessment with fractional flow reserve and instantaneous wave-free ratio.
    Catheter Cardiovasc Interv. 2022;99:1104-1114.
    PubMed     Abstract available


  384. NAN TIE E, Fernando H, Nehme Z, Dinh D, et al
    Sex differences in prehospital analgesia in patients presenting with acute coronary syndromes and their association with clinical outcomes.
    Catheter Cardiovasc Interv. 2022;99:989-995.
    PubMed     Abstract available


  385. HANSEN KN, Maeng M, Raungaard B, Engstrom T, et al
    Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
    Catheter Cardiovasc Interv. 2022;99:1095-1103.
    PubMed     Abstract available


  386. BARKHOLT TO, Neghabat O, Holck EN, Andreasen LN, et al
    Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Catheter Cardiovasc Interv. 2022;99:1075-1083.
    PubMed     Abstract available


  387. WILLIAMS T, Mittal A, Karageorgiev D, Iniguez Romo A, et al
    Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry.
    Catheter Cardiovasc Interv. 2022;99:961-967.
    PubMed     Abstract available


    February 2022
  388. ARCHILLETTI F, Giuliani L, Dangas GD, Ricci F, et al
    Timing of mechanical circulatory support during primary angioplasty in acute myocardial infarction and cardiogenic shock: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Feb 19. doi: 10.1002/ccd.30137.
    PubMed     Abstract available


  389. SUI Y, Yang M, Xu Y, Wu N, et al
    Diagnostic performance of intravascular ultrasound-based fractional flow reserve versus angiography-based quantitative flow ratio measurements for evaluating left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2022 Feb 7. doi: 10.1002/ccd.30078.
    PubMed     Abstract available


  390. VALVO R, Costa G, Tamburino C, Barbanti M, et al
    Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30116.
    PubMed     Abstract available


  391. HANNA EB, Rossen J, Eustes AS, Dayal S, et al
    Heavy lone coronary artery thrombosis treated by stent retriever, in the setting of COVID-19 infection.
    Catheter Cardiovasc Interv. 2022;99:457-461.
    PubMed     Abstract available


  392. KITE TA, Ladwiniec A, Owens CG, Chase A, et al
    Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
    Catheter Cardiovasc Interv. 2022;99:305-313.
    PubMed     Abstract available


  393. KHAN AA, Dangas G
    Is cardiac surgery backup required for left main stenting?
    Catheter Cardiovasc Interv. 2022;99:607-608.
    PubMed    


  394. ALASNAG M
    Sound and light editorial: The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2022;99:674-675.
    PubMed    


  395. TARANTINI G, Cardaioli F
    Coronary complete revascularization strategy: A puzzle still hard to complete.
    Catheter Cardiovasc Interv. 2022;99:639-640.
    PubMed    


  396. GOLDSTEIN JA, Mehta NK
    Extent of coronary atherosclerosis and ischemic myocardium foment sudden cardiac death.
    Catheter Cardiovasc Interv. 2022;99:812-813.
    PubMed    


  397. MARCHESE N, Barbato E, Di Gioia G, Stanislao M, et al
    Intracoronary pressures to predict myocardial viability in patients with ischemic left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2022;99:271-279.
    PubMed     Abstract available


  398. LOW RJB, Khoo DZL, Ong PJL
    Case report: A novel application of the MicroVascular Plug (MVP) in treating distal coronary perforation.
    Catheter Cardiovasc Interv. 2022;99:502-507.
    PubMed     Abstract available


  399. HIDALGO F, Gonzalez-Manzanares R, Ojeda S, Benito-Gonzalez T, et al
    Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.
    Catheter Cardiovasc Interv. 2022;99:489-496.
    PubMed     Abstract available


  400. XU R, Shi Y, Chang S, Qin Q, et al
    Outcomes of contemporary versus conventional reverse controlled and antegrade and retrograde subintimal tracking in chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2022;99:226-233.
    PubMed     Abstract available


  401. LEE K, Lee PH, Lee SW, Kwon O, et al
    Primary versus rescue retrograde approach for chronic total coronary occlusion.
    Catheter Cardiovasc Interv. 2022;99:219-225.
    PubMed     Abstract available


  402. FEENSTRA RGT, van Lavieren MA, Echavarria-Pinto M, Wijntjens GW, et al
    Respiration-related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration.
    Catheter Cardiovasc Interv. 2022;99:844-852.
    PubMed     Abstract available


  403. KANDZARI DE, Alaswad K, Jaffer FA, Brilakis E, et al
    Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
    Catheter Cardiovasc Interv. 2022;99:263-270.
    PubMed     Abstract available


  404. KANDZARI DE, Kirtane AJ, Mehran R, Price MJ, et al
    Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
    Catheter Cardiovasc Interv. 2022;99:583-592.
    PubMed     Abstract available


  405. CUENIN L, Honton B, Aminfar F, Meyer P, et al
    Head to head comparison of quantitative flow ratio using 4-French and 6-French catheters versus fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:746-753.
    PubMed     Abstract available


  406. WIEBE J, Hofmann FJ, West N, Baumbach A, et al
    Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.
    Catheter Cardiovasc Interv. 2022;99:533-540.
    PubMed     Abstract available


  407. NOGIC J, Nerlekar N, Soon K, Freeman M, et al
    Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry.
    Catheter Cardiovasc Interv. 2022;99:554-562.
    PubMed     Abstract available


  408. EBERLI FR, Stoll HP, Urban P, Morice MC, et al
    Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
    Catheter Cardiovasc Interv. 2022;99:593-600.
    PubMed     Abstract available


  409. KOSMOPOULOS M, Bartos JA, Raveendran G, Goslar T, et al
    Coronary artery disease burden relation with the presentation of acute cardiac events and ventricular fibrillation.
    Catheter Cardiovasc Interv. 2022;99:804-811.
    PubMed     Abstract available


  410. HUSSAIN Y, Gaston S, Kluger J, Shah T, et al
    Long term outcomes of ultrathin versus standard thickness second-generation drug eluting stents: Meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2022;99:563-574.
    PubMed     Abstract available


  411. G TOTH G, Collet C, Langhoff Thuesen A, Mizukami T, et al
    Influence of fractional flow reserve on grafts patency: Systematic review and patient-level meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:730-735.
    PubMed     Abstract available


  412. MCINERNEY A, Travieso Gonzalez A, Castro Mejia A, Tirado-Conte G, et al
    Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:723-729.
    PubMed     Abstract available


  413. HARDING SA, Webber B, Fairley S, Ormiston JA, et al
    Real-time intravascular ultrasound guidance: A novel technique for accurate placement of ostial stents.
    Catheter Cardiovasc Interv. 2022;99:699-705.
    PubMed     Abstract available


  414. HAKEEM A, Hou L, Shah K, Agarwal SK, et al
    Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry.
    Catheter Cardiovasc Interv. 2022;99:714-722.
    PubMed     Abstract available


  415. SCARSINI R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, et al
    Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.
    Catheter Cardiovasc Interv. 2022;99:329-339.
    PubMed     Abstract available


  416. OSMAN M, Ghaffar YA, Osman K, Kheiri B, et al
    Gender-based outcomes of coronary bifurcation stenting: A report from the National Readmission Database.
    Catheter Cardiovasc Interv. 2022;99:433-439.
    PubMed     Abstract available


  417. VAN HEMERT ND, Rozemeijer R, Voskuil M, Stein M, et al
    Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
    Catheter Cardiovasc Interv. 2022;99:366-372.
    PubMed     Abstract available


  418. IQBAL MB, Moore PT, Nadra IJ, Robinson SD, et al
    Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2022;99:627-638.
    PubMed     Abstract available


  419. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    PubMed     Abstract available


  420. SAITO Y, Wijns W, Baumbach A, Xu B, et al
    Differential impact of abluminal groove-filled biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent on and off dual antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;99:357-365.
    PubMed     Abstract available


    January 2022
  421. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    PubMed     Abstract available


  422. HONG XL, Li Y, Fu GS, Zhang WB, et al
    Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
    PubMed     Abstract available


  423. CHEN S, Li J, Qiu M, Ma S, et al
    Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
    PubMed     Abstract available


  424. LI J, Liu X, Ma S, Na K, et al
    Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
    PubMed     Abstract available


  425. YUAN S, He J, Cai Z, Zhang R, et al
    Intra-aortic balloon pump in cardiogenic shock: A propensity score matching analysis.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30102.
    PubMed     Abstract available


  426. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    PubMed     Abstract available


  427. LAWLOR MK, Hamid N, Kampaktsis P, Ning Y, et al
    Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30073.
    PubMed     Abstract available


  428. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    PubMed     Abstract available


  429. LI Y, Li J, Qiu M, Ma S, et al
    Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
    PubMed     Abstract available


  430. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    PubMed     Abstract available


  431. TARANTINI G, Rodino G
    The role of Impella percutaneous left ventricular assist device in the management of cardiogenic shock: A matter of where and when.
    Catheter Cardiovasc Interv. 2022;99:48-49.
    PubMed    


  432. SPIRITO A, Mehran R
    Prolonged dual antiplatelet therapy in selected patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;99:114-115.
    PubMed    


  433. IMPROTA R, Scarparo P, Wilschut J, Wolff Q, et al
    Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.
    Catheter Cardiovasc Interv. 2022;99:88-97.
    PubMed     Abstract available


  434. WANG HY, Mo R, Guan CD, Wang Y, et al
    Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;99:98-113.
    PubMed     Abstract available


  435. NOURI SN, Malick W, Masoumi A, Fried JA, et al
    Impella percutaneous left ventricular assist device as mechanical circulatory support for cardiogenic shock: A retrospective analysis from a tertiary academic medical center.
    Catheter Cardiovasc Interv. 2022;99:37-47.
    PubMed     Abstract available


    December 2021
  436. DEMIR OM, Little CD, Jabbour R, Rahman H, et al
    Impact of COVID-19 pandemic on the management of nonculprit lesions in patients presenting with ST-elevation myocardial infarction: Outcomes from the pan-London heart attack centers.
    Catheter Cardiovasc Interv. 2021 Dec 30. doi: 10.1002/ccd.30056.
    PubMed     Abstract available


  437. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2021 Dec 28. doi: 10.1002/ccd.30049.
    PubMed     Abstract available


  438. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    PubMed     Abstract available


  439. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    PubMed     Abstract available


  440. KAFKAS N, Dragasis S, Mantis C, Floros G, et al
    Myocardial infarction with non obstructive coronary arteries complicated with ventricular septal rupture: A case report and literature review.
    Catheter Cardiovasc Interv. 2021 Dec 1. doi: 10.1002/ccd.30028.
    PubMed     Abstract available


  441. TOMEY MI, Dangas GD
    Risk prediction in cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;98:1285-1286.
    PubMed    


  442. TOPAZ O
    Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
    Catheter Cardiovasc Interv. 2021;98:1250-1251.
    PubMed    


  443. KLEIN LW, Tamis-Holland J, Kirtane AJ, Anderson HV, et al
    The appropriate use criteria: Improvements for its integration into real world clinical practice.
    Catheter Cardiovasc Interv. 2021;98:1349-1357.
    PubMed     Abstract available


  444. MARASHLY Q, Taleb I, Kyriakopoulos CP, Dranow E, et al
    Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score.
    Catheter Cardiovasc Interv. 2021;98:1275-1284.
    PubMed     Abstract available


  445. CHICHAREON P, van Klaveren D, Modolo R, Kogame N, et al
    Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.
    Catheter Cardiovasc Interv. 2021;98:1287-1297.
    PubMed     Abstract available


  446. VERDOIA M, Rolla R, Pergolini P, Gioscia R, et al
    Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor.
    Catheter Cardiovasc Interv. 2021;98:1309-1316.
    PubMed     Abstract available


  447. ABHYANKAR A, Abizaid A, Chamie D, Patel G, et al
    Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:1335-1342.
    PubMed     Abstract available


  448. KOUTOUZIS M, Liontou C, Xenogiannis I, Tajti P, et al
    Same day discharge after chronic total occlusion interventions: A single center experience.
    Catheter Cardiovasc Interv. 2021;98:1232-1239.
    PubMed     Abstract available


    November 2021
  449. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    PubMed     Abstract available


  450. AKL E, Pinilla-Echeverri N, Garcia-Garcia HM, Mehta SR, et al
    First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30001.
    PubMed     Abstract available


  451. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    PubMed     Abstract available


  452. VALLURUPALLI S, Salehi N, Agarwal S, Hasan R, et al
    Exhaustion of coronary vasodilatory reserve in the resting state: Clinical characteristics and long-term outcomes after intervention.
    Catheter Cardiovasc Interv. 2021;98:1021-1026.
    PubMed     Abstract available


  453. DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
    Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
    Catheter Cardiovasc Interv. 2021;98:1144-1151.
    PubMed    


  454. MEHTA S, Grines CL, Botelho R, Fernandez F, et al
    STEMI telemedicine for 100 million lives.
    Catheter Cardiovasc Interv. 2021;98:1066-1071.
    PubMed     Abstract available


  455. CERRATO E, Belliggiano D, Quadri G, Erriquez A, et al
    Anatomical and functional healing after resorbable magnesium scaffold implantation in human coronary vessels: A combined optical coherence tomography and quantitative flow ratio analysis.
    Catheter Cardiovasc Interv. 2021;98:1038-1046.
    PubMed     Abstract available


  456. JACKEL M, Zotzmann V, Wengenmayer T, Duerschmied D, et al
    Incidence and predictors of delirium on the intensive care unit after acute myocardial infarction, insight from a retrospective registry.
    Catheter Cardiovasc Interv. 2021;98:1072-1081.
    PubMed     Abstract available


  457. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    PubMed    


  458. KIRRESH A, Candilio L, Stone GW
    Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: Review and recommendations.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30008.
    PubMed     Abstract available


  459. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    PubMed     Abstract available


  460. SCARSINI R, Fezzi S, Pesarini G, Del Sole PA, et al
    Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy.
    Catheter Cardiovasc Interv. 2021 Nov 10. doi: 10.1002/ccd.30007.
    PubMed     Abstract available


  461. QUESADA O, Henry TD
    Functional coronary angiography for coronary microvascular function: the time has come!
    Catheter Cardiovasc Interv. 2021;98:836-837.
    PubMed    


  462. KALETA FP, Gilchrist IC
    PRECISE-DAPT: A tool to measure if Afib patients may risk being stretched too thin.
    Catheter Cardiovasc Interv. 2021;98:846-847.
    PubMed    


  463. KUMAR S, Mehta PK, Eshtehardi P, Hung OY, et al
    Functional coronary angiography in symptomatic patients with no obstructive coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:827-835.
    PubMed     Abstract available


  464. TOELG R, Slagboom T, Waltenberger J, Lefevre T, et al
    Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.
    Catheter Cardiovasc Interv. 2021;98:848-856.
    PubMed     Abstract available


  465. GUPTA A, Seth A
    Oral anticoagulants for coronary artery aneurysm: For few or for all?
    Catheter Cardiovasc Interv. 2021;98:872-873.
    PubMed    


  466. WANI O, Butman SM
    Auf wiedersehen coronary stenosis? Not so fast mein Herr.
    Catheter Cardiovasc Interv. 2021;98:863.
    PubMed    


  467. PARK H, Kang DY, Kim SO, Lee J, et al
    Ten-year outcomes of early generation sirolimus- versus paclitaxel-eluting stents in patients with left main coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E705-E714.
    PubMed     Abstract available


  468. NOGUCHI M, Dohi T, Okazaki S, Matsumura M, et al
    Comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:E677-E686.
    PubMed     Abstract available


  469. CANDREVA A, Mizukami T, Sonck J, Munhoz D, et al
    Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pullback pressure gradients.
    Catheter Cardiovasc Interv. 2021;98:E647-E654.
    PubMed     Abstract available


  470. FAGEL ND, Amoroso G, Rabbering T, Gescher F, et al
    One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.
    Catheter Cardiovasc Interv. 2021;98:E661-E667.
    PubMed     Abstract available


  471. KHAN AA, Murtaza G, Khalid MF, White CJ, et al
    Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:884-892.
    PubMed     Abstract available


  472. HERNANDEZ-ENRIQUEZ M, Belle L, Madiot H, Pansieri M, et al
    Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry.
    Catheter Cardiovasc Interv. 2021;98:874-881.
    PubMed     Abstract available


  473. MILEWSKI K, Bryla-Wojciechowska A, Buszman PP, Jelonek K, et al
    Nanospheres encapsulated everolimus delivery into arterial wall-the tissue pharmacokinetics and vascular response experimental study.
    Catheter Cardiovasc Interv. 2021;98:914-922.
    PubMed     Abstract available


  474. SALINAS P, Sanchez-Casanueva RM, Gonzalo N, A Gil J, et al
    Dose-reducing fluoroscopic system decreases patient but not occupational radiation exposure in chronic total occlusion intervention.
    Catheter Cardiovasc Interv. 2021;98:895-902.
    PubMed     Abstract available


  475. D'ASCENZO F, Saglietto A, Ramakrishna H, Andreis A, et al
    Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry.
    Catheter Cardiovasc Interv. 2021;98:864-871.
    PubMed     Abstract available


  476. WIEBE J, Rai H, Kuna C, Cassese S, et al
    Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Catheter Cardiovasc Interv. 2021;98:857-862.
    PubMed     Abstract available


    October 2021
  477. SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
    Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
    Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
    PubMed     Abstract available


  478. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    PubMed     Abstract available


  479. HILLEGASS WB
    Diabetes and everolimus eluting bioresorbable poly-L-lactide vascular scaffolds for coronary artery disease: Dead-end or some path forward?
    Catheter Cardiovasc Interv. 2021;98:721-722.
    PubMed    


  480. LANTZ R, Henry TD
    STEMI in 90-year-olds: The good news and the bad news!
    Catheter Cardiovasc Interv. 2021;98:647-648.
    PubMed    


  481. KOH JS, Gogas BD, Kumar S, Benham JJ, et al
    Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;98:723-732.
    PubMed     Abstract available


  482. BOEDER NF, Kastner J, Mehilli J, Munzel T, et al
    Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.
    Catheter Cardiovasc Interv. 2021;98:E555-E563.
    PubMed     Abstract available


  483. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    PubMed     Abstract available


  484. TROBS M, Achenbach S, Nef HM, Gori T, et al
    Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:E564-E570.
    PubMed     Abstract available


  485. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    PubMed     Abstract available


  486. ONO M, Kawashima H, Hara H, Gamal A, et al
    External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2021;98:E513-E522.
    PubMed     Abstract available


  487. MEMON S, George JC, Kalra S, Janzer S, et al
    Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent.
    Catheter Cardiovasc Interv. 2021;98:743-747.
    PubMed     Abstract available


  488. KERKMEIJER LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, et al
    Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
    Catheter Cardiovasc Interv. 2021;98:713-720.
    PubMed     Abstract available


  489. SAPONTIS J, Hirai T, Patterson C, Gans B, et al
    Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) stud
    Catheter Cardiovasc Interv. 2021;98:626-635.
    PubMed     Abstract available


  490. KINI AS, Okamoto N, Barman N, Vengrenyuk Y, et al
    Side branch fractional flow reserve after provisional stenting of calcified bifurcation lesions: The ORBID-FFR study.
    Catheter Cardiovasc Interv. 2021;98:658-668.
    PubMed     Abstract available


  491. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    PubMed     Abstract available


  492. VETROVEC GW, Lim MJ, Needham KA
    Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: An episode-of-care analysis.
    Catheter Cardiovasc Interv. 2021;98:703-710.
    PubMed     Abstract available


  493. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2021;98:617-625.
    PubMed     Abstract available


    September 2021
  494. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    PubMed     Abstract available


  495. WATANABE Y, Mitomo S, Naganuma T, Chieffo A, et al
    The importance of proximal optimization technique with intravascular imaging guided for stenting unprotected left main distal bifurcation lesions: The Milan and New-Tokyo registry.
    Catheter Cardiovasc Interv. 2021 Sep 14. doi: 10.1002/ccd.29954.
    PubMed     Abstract available


  496. ULLAH W, Zghouzi M, Ahmad B, Suleiman AM, et al
    Safety and efficacy of the polymer-free and polymer-coated drug-eluting stents in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Sep 12. doi: 10.1002/ccd.29953.
    PubMed     Abstract available


  497. BEERKENS FJ, Singh R, Cao D, Claessen BE, et al
    Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
    Catheter Cardiovasc Interv. 2021 Sep 3. doi: 10.1002/ccd.29935.
    PubMed     Abstract available


  498. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    PubMed    


  499. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    PubMed     Abstract available


  500. TZANIS G, Khokhar AA, Ponticelli F, Gallone G, et al
    Coronary sinus size and ischemia improvement after reducer implantation; "one size to fit them all?"
    Catheter Cardiovasc Interv. 2021;98:E365-E369.
    PubMed     Abstract available


  501. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    PubMed     Abstract available


  502. CORDERO A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, et al
    Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
    Catheter Cardiovasc Interv. 2021;98:E342-E350.
    PubMed     Abstract available


  503. WU EB
    Rebuttal: Misconceptions in crossboss/stingray catheter use-Clarification from the hybrid group.
    Catheter Cardiovasc Interv. 2021;98:616.
    PubMed    


  504. PERSHAD A, Grantham JA, Thompson CA, Lombardi WL, et al
    Misconception in CrossBoss/stingray catheter use-clarification from the hybrid group.
    Catheter Cardiovasc Interv. 2021;98:615.
    PubMed    


  505. LHERMUSIER T, Carrie D, Cayla G, Fajadet J, et al
    Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:511-519.
    PubMed     Abstract available


  506. YAGER N, Schulman-Marcus J, Torosoff M
    Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:436-444.
    PubMed     Abstract available


  507. KERKMEIJER LSM, Chandrasekhar J, Kalkman DN, Woudstra P, et al
    Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Catheter Cardiovasc Interv. 2021;98:503-510.
    PubMed     Abstract available


  508. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    PubMed     Abstract available


  509. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    PubMed     Abstract available


  510. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    PubMed     Abstract available


  511. LEE JH, Kim U, Kim JS, Hong SJ, et al
    Clinical implication of neointimal burden in in-stent restenosis treated with drug-coated balloon.
    Catheter Cardiovasc Interv. 2021;98:493-502.
    PubMed     Abstract available


  512. JANG WJ, Chun WJ, Park IH, Choi KH, et al
    Impact of stent designs of second-generation drug-eluting stents on long-term outcomes in coronary bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;98:458-467.
    PubMed     Abstract available


    August 2021
  513. LICHAA H
    Coronary stent positioning under live IVUS guidance in low contrast percutaneous coronary interventions: The live IVUS stenting technique.
    Catheter Cardiovasc Interv. 2021 Aug 31. doi: 10.1002/ccd.29940.
    PubMed     Abstract available


  514. CHANG CW, Wadia SK, Rastogi A, Stinis CT, et al
    A unique cause of coronary obstruction after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29919.
    PubMed     Abstract available


  515. YIN T, Zhong X, Tao L, Hu T, et al
    Revascularization by percutaneous coronary intervention in a case of left main coronary artery atresia.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29931.
    PubMed     Abstract available


  516. ERDOGAN E, Huang X, Cooper J, Jain A, et al
    End-diastolic segmentation of intravascular ultrasound images enables more reproducible volumetric analysis of atheroma burden.
    Catheter Cardiovasc Interv. 2021 Aug 17. doi: 10.1002/ccd.29917.
    PubMed     Abstract available


  517. TEHRANI DM, Seto AH
    Acute kidney injury in cardiogenic shock: The powerful distortions of survivor bias.
    Catheter Cardiovasc Interv. 2021;98:341-342.
    PubMed    


  518. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    PubMed     Abstract available


  519. LI C, Yang J, Dong S, Dong L, et al
    Multicenter clinical evaluation of a piezoresistive-MEMS-sensor rapid-exchange pressure microcatheter system for fractional flow reserve measurement.
    Catheter Cardiovasc Interv. 2021;98:E243-E253.
    PubMed     Abstract available


  520. PADKINS M, Breen T, Van Diepen S, Barsness G, et al
    Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity.
    Catheter Cardiovasc Interv. 2021;98:330-340.
    PubMed     Abstract available


  521. ZHAO Y, Li J, Ma S, Jiang Z, et al
    Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2021;98:E235-E242.
    PubMed     Abstract available


  522. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    PubMed     Abstract available


  523. MAATMAN B, Rios-Meza H, Guglin M, Revtyak G, et al
    A safe and simple method for axIABP placement using a left axillary-radial technique.
    Catheter Cardiovasc Interv. 2021;98:E310-E314.
    PubMed     Abstract available


  524. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    PubMed     Abstract available


  525. SANZ SANCHEZ J, Garbo R, Gagnor A, Oreglia J, et al
    Management and outcomes of coronary artery perforations treated with the block and deliver technique.
    Catheter Cardiovasc Interv. 2021;98:238-245.
    PubMed     Abstract available


  526. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:197-205.
    PubMed     Abstract available


  527. BODE WD, Bode MF
    Chronic total occlusion revascularization for ventricular arrhythmias?-Still more work to be done.
    Catheter Cardiovasc Interv. 2021;98:409.
    PubMed    


  528. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:E324.
    PubMed    


  529. NAVARRO CASTELLANOS I, Dahdah N
    Letter to the Editor concerning the article: "Comparison of drug eluting versus bare metal stents".
    Catheter Cardiovasc Interv. 2021;98:E325.
    PubMed    


  530. DUNN AN, Huded C, Simpfendorfer C, Raymond R, et al
    End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
    Catheter Cardiovasc Interv. 2021;98:246-254.
    PubMed     Abstract available


    July 2021
  531. BISWAS S, Dinh D, Duffy SJ, Brennan A, et al
    Characteristics and outcomes of unsuccessful percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29886.
    PubMed     Abstract available


  532. SCHUMACHER SP, Everaars H, Stuijfzand WJ, van Diemen PA, et al
    Viability and functional recovery after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 30. doi: 10.1002/ccd.29888.
    PubMed     Abstract available


  533. MARCUSOHN E, Zukermann R, Kerner A, Roguin A, et al
    Long-term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29870.
    PubMed     Abstract available


  534. MEJIA-RENTERIA H, Lee JM, Choi KH, Lee SH, et al
    Coronary microcirculation assessment using functional angiography: Development of a wire-free method applicable to conventional coronary angiograms.
    Catheter Cardiovasc Interv. 2021 Jul 9. doi: 10.1002/ccd.29863.
    PubMed     Abstract available


  535. DAI Y, Ge J
    The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
    Catheter Cardiovasc Interv. 2021;98:43-44.
    PubMed    


  536. VETROVEC GW
    Preventing NSTEMI readmissions: Starting from the beginning.
    Catheter Cardiovasc Interv. 2021;98:22-23.
    PubMed    


  537. AZZALINI L, Carlino M
    A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry.
    Catheter Cardiovasc Interv. 2021;98:E85-E90.
    PubMed     Abstract available


  538. TAHIR H, Tonks R, Cox J, Baljepally R, et al
    Optimizing mechanical circulatory support hemodynamics using coronary sinus pacing.
    Catheter Cardiovasc Interv. 2021;98:E78-E84.
    PubMed     Abstract available


  539. DAHAL S, Budoff MJ
    Anatomic burden mostly outperforms ischemic burden: From COURAGE to ISCHEMIA.
    Catheter Cardiovasc Interv. 2021;98:E106-E107.
    PubMed    


  540. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    PubMed     Abstract available


  541. WATANABE Y, Mitomo S, Naganuma T, Takagi K, et al
    Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry.
    Catheter Cardiovasc Interv. 2021;98:E24-E34.
    PubMed     Abstract available


  542. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    PubMed     Abstract available


  543. VERHEYE S, Wlodarczak A, Montorsi P, Torzewski J, et al
    BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.
    Catheter Cardiovasc Interv. 2021;98:E1-E8.
    PubMed     Abstract available


  544. SHEIKH O, Nguyen T, Bansal S, Prasad A, et al
    Acute kidney injury in cardiogenic shock: A comprehensive review.
    Catheter Cardiovasc Interv. 2021;98:E91-E105.
    PubMed     Abstract available


  545. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2021;98:12-21.
    PubMed     Abstract available


  546. BRIGUORI C, Golino M, Porchetta N, Scarpelli M, et al
    Impact of a contrast media volume control device on acute kidney injury rate in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;98:76-84.
    PubMed     Abstract available


  547. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    PubMed     Abstract available


  548. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    PubMed     Abstract available


  549. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2021;98:45-54.
    PubMed     Abstract available


  550. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    PubMed     Abstract available


    June 2021
  551. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    PubMed     Abstract available


  552. KERN MJ, Seto AH
    Post-dilation in ST-elevation MI patients makes sense anatomically, but does it improve physiology?
    Catheter Cardiovasc Interv. 2021;97:1318-1319.
    PubMed    


  553. BELARDI JA, Lamelas PM
    Contemporary stents: Tough to get better.
    Catheter Cardiovasc Interv. 2021;97:1352-1353.
    PubMed    


  554. NAGARAJA V, Rao SV, George S, Mamas M, et al
    Evidence-based arterial access site practice in patients with acute coronary syndromes: Has SAFARI-STEMI changed the landscape?
    Catheter Cardiovasc Interv. 2021;97:1417-1421.
    PubMed    


  555. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    PubMed     Abstract available


  556. WILGENHOF A, Zivelonghi C, Verheye S, Vermeersch P, et al
    Coronary sinus anatomical features: Description and procedural implications during coronary sinus Reducer implantation.
    Catheter Cardiovasc Interv. 2021;97:E929-E935.
    PubMed     Abstract available


  557. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Brilakis ES, et al
    Combined use of intravascular lithotripsy and brachytherapy: A new approach for the treatment of recurrent coronary in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97:1402-1406.
    PubMed     Abstract available


  558. ANDO G, Capodanno D
    Safe femoral access for STEMI patients and mortality in the new decade: Back to the future?
    Catheter Cardiovasc Interv. 2021;97:E1054-E1056.
    PubMed    


  559. PATEL NJ, Okamoto N, Murphy J, Vengrenyuk Y, et al
    Management of calcified coronary artery bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:1407-1416.
    PubMed     Abstract available


  560. TEHRANI BN, Damluji AA, Sherwood MW, Rosner C, et al
    Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.
    Catheter Cardiovasc Interv. 2021;97:1354-1366.
    PubMed     Abstract available


  561. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    PubMed     Abstract available


  562. LI X, Kan J, She L, Shrestha R, et al
    Optical coherence tomography predictors of target vessel myocardial infarction after provisional stenting in patients with coronary bifurcation disease.
    Catheter Cardiovasc Interv. 2021;97:1331-1340.
    PubMed     Abstract available


  563. AZZALINI L, Baber U, Johal GS, Farhan S, et al
    One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;97:1341-1351.
    PubMed     Abstract available


  564. KURIHARA O, Shinohara H, Kim HO, Russo M, et al
    Comparison of post-stent optical coherence tomography findings: Layered versus non-layered culprit lesions.
    Catheter Cardiovasc Interv. 2021;97:1320-1328.
    PubMed     Abstract available


  565. KARAMASIS GV, Kalogeropoulos AS, Gamma RA, Clesham GJ, et al
    Effects of stent postdilatation during primary PCI for STEMI: Insights from coronary physiology and optical coherence tomography.
    Catheter Cardiovasc Interv. 2021;97:1309-1317.
    PubMed     Abstract available


  566. KAUL U, Abhyankar A, K Abhaichand R, Bhagwat A, et al
    Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography.
    Catheter Cardiovasc Interv. 2021 Jun 1. doi: 10.1002/ccd.29794.
    PubMed     Abstract available


    May 2021
  567. JENTZER JC, van Diepen S, Henry TD, Baran DA, et al
    Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity.
    Catheter Cardiovasc Interv. 2021 May 28. doi: 10.1002/ccd.29800.
    PubMed     Abstract available


  568. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    PubMed     Abstract available


  569. SHOAIB A, Mohamed M, Curzen N, Ludman P, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29691.
    PubMed     Abstract available


  570. TOPAZ O
    The inconsistency of manual thrombectomy and the role of contemporary thrombus grading in PCI for STEMI.
    Catheter Cardiovasc Interv. 2021;97:1149-1150.
    PubMed    


  571. GUDDETI RR, Brilakis ES
    With great power comes great responsibility: When and how to use the retrograde approach to chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2021;97:1174-1175.
    PubMed    


  572. SHADMAN S, Heyliger S, Watts C, Aghili N, et al
    Successful impella-assisted suction thrombectomy of right heart thrombus via the AngioVac device: Advantages, limitations, and alternatives.
    Catheter Cardiovasc Interv. 2021;97:1296-1300.
    PubMed     Abstract available


  573. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    PubMed     Abstract available


  574. LEMOR A, Al-Darzi W, O'Neill W, Basir MB, et al
    Unmasking right ventricular failure in cardiogenic shock: The importance of serial hemodynamics.
    Catheter Cardiovasc Interv. 2021;97:1209-1212.
    PubMed     Abstract available


  575. ALLAHWALA UK, Nour D, Bhatia K, Ward MR, et al
    Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta-analysis of over 3,000 patients.
    Catheter Cardiovasc Interv. 2021;97:E771-E777.
    PubMed     Abstract available


  576. MEDRANDA GA, Lance S, Waksman R, Bernardo NL, et al
    Colossal left main to right atrium fistula ligation complicated by left circumflex STEMI.
    Catheter Cardiovasc Interv. 2021;97:1218-1220.
    PubMed     Abstract available


  577. KALRA S, Doshi D, Sapontis J, Kosmidou I, et al
    Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:1162-1173.
    PubMed     Abstract available


  578. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    PubMed     Abstract available


  579. WERNER GS, Yaginuma K, Koch M, Tischer K, et al
    Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention.
    Catheter Cardiovasc Interv. 2021;97:1196-1206.
    PubMed     Abstract available


  580. CHEN S, David SW, Khan ZA, Metzger DC, et al
    One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2021;97:1120-1126.
    PubMed     Abstract available


  581. VOGT JC, Manning PG, Sheikh O, Aronow HD, et al
    The role of rivaroxaban for patients with atherosclerotic vascular disease in the modern era.
    Catheter Cardiovasc Interv. 2021;97:1221-1229.
    PubMed    


  582. KIM MC, Bae S, Ahn Y, Sim DS, et al
    Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification.
    Catheter Cardiovasc Interv. 2021;97:1151-1159.
    PubMed     Abstract available


  583. PAHUJA M, Ranka S, Chehab O, Mishra T, et al
    Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:1129-1138.
    PubMed     Abstract available


  584. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2021;97:1186-1193.
    PubMed     Abstract available


  585. GARCIA S, Schmidt CW, Garberich R, Henry TD, et al
    Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
    Catheter Cardiovasc Interv. 2021;97:1109-1117.
    PubMed     Abstract available


  586. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2021;97:1176-1183.
    PubMed     Abstract available


  587. MEIER D, Fournier S, Masci PG, Eeckhout E, et al
    Impact of manual thrombectomy on microvascular obstruction in STEMI patients.
    Catheter Cardiovasc Interv. 2021;97:1141-1148.
    PubMed     Abstract available


  588. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    PubMed     Abstract available


  589. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    PubMed     Abstract available


  590. REN Y, Li X, Wang S, Pan W, et al
    Serum alkaline phosphatase levels are associated with coronary artery calcification patterns and plaque vulnerability.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1055-1062.
    PubMed     Abstract available


  591. LI X, Qiu M, Na K, Li Y, et al
    Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1032-1039.
    PubMed     Abstract available


    April 2021
  592. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    PubMed     Abstract available


  593. PAGNONI M, Meier D, Candreva A, Maillard L, et al
    Future culprit detection based on angiography-derived FFR.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29736.
    PubMed     Abstract available


  594. XU M, Demuyakor A, Hu S, Liu H, et al
    Is the effect of atorvastatin 60 mg on stabilization of lipid-rich plaque equivalent to that of rosuvastatin 10 mg? A serial optical coherence tomography combined with intravascular ultrasound imaging.
    Catheter Cardiovasc Interv. 2021 Apr 17. doi: 10.1002/ccd.29654.
    PubMed     Abstract available


  595. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    PubMed     Abstract available


  596. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    PubMed     Abstract available


  597. NAKAMURA S, Yonetsu T, Hoshino M, Hada M, et al
    Anatomical-functional discordance between quantitative coronary angiography and diastolic pressure ratio during wave-free period.
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29680.
    PubMed     Abstract available


  598. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    PubMed     Abstract available


    March 2021
  599. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    PubMed     Abstract available


  600. TU S, Ding D, Chang Y, Li C, et al
    Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: A novel method based on bifurcation fractal law.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29592.
    PubMed     Abstract available


  601. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    PubMed     Abstract available


    February 2021
  602. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    PubMed     Abstract available


  603. TAO L, Li Z, Yin Z, Lin W, et al
    Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Feb 19. doi: 10.1002/ccd.29553.
    PubMed     Abstract available


  604. ALEJANDRO GB, Gheorghe LL, Camacho Freire S, Silva E, et al
    Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29557.
    PubMed     Abstract available


  605. GONG Y, Zheng B, Yi T, Yang F, et al
    Coronary angiography-derived contrast fractional flow reserve.
    Catheter Cardiovasc Interv. 2021 Feb 15. doi: 10.1002/ccd.29558.
    PubMed     Abstract available


  606. ALAOUR B, Onwordi E, Khan A, Menexi C, et al
    Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5-year clinical experience.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29530.
    PubMed     Abstract available


  607. BRUNO F, De Filippo O, Conrotto F, D'Ascenzo F, et al
    Response to: Angiography versus FFR-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 7. doi: 10.1002/ccd.29542.
    PubMed    


  608. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    PubMed     Abstract available


  609. SHIELDS MC, Ouellette M, Kiefer N, Kohan L, et al
    Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29508.
    PubMed     Abstract available


  610. SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
    Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
    PubMed     Abstract available


  611. PAHUJA M, Chehab O, Ranka S, Mishra T, et al
    Incidence and clinical outcomes of stroke in ST-elevation myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:217-225.
    PubMed     Abstract available


    January 2021
  612. HIRAI T, Grantham JA, Sapontis J, Nicholson WJ, et al
    Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score.
    Catheter Cardiovasc Interv. 2021 Jan 13. doi: 10.1002/ccd.29466.
    PubMed     Abstract available


    December 2020
  613. SCOTTI A, Godino C, Munafo A, Pivato CA, et al
    Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29425.
    PubMed     Abstract available


  614. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    PubMed     Abstract available


  615. ABIZAID A, Kedev S, Ali RBM, Santoso T, et al
    Imaging and 2-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: The MeRes-1 extend trial.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29396.
    PubMed     Abstract available


    November 2020
  616. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    PubMed     Abstract available


  617. AHSAN MJ, Lateef N, Latif A, Malik SU, et al
    A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 24. doi: 10.1002/ccd.29405.
    PubMed     Abstract available


  618. PROTTY MB, Gallagher S, Farooq V, Sharp AS, et al
    Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2020 Nov 17. doi: 10.1002/ccd.29377.
    PubMed     Abstract available


  619. SUGIYAMA T, Kanno Y, Hamaya R, Kanaji Y, et al
    Determinants of visual-functional mismatches as assessed by coronary angiography and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2020 Nov 16. doi: 10.1002/ccd.29388.
    PubMed     Abstract available


    October 2020
  620. JONES TL, Golomb M, Dranow E, Welt FGP, et al
    The case for a qualitative lesion assessment system for coronary angiography.
    Catheter Cardiovasc Interv. 2020 Oct 31. doi: 10.1002/ccd.29334.
    PubMed     Abstract available


  621. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    PubMed     Abstract available


  622. ALRAIES MC, Al-Khadra Y
    Heterogeneity of Impella use in the United States for high-risk coronary interventions.
    Catheter Cardiovasc Interv. 2020 Oct 24. doi: 10.1002/ccd.29346.
    PubMed    


  623. YAMAMOTO K, Shiomi H, Morimoto T, Takeji Y, et al
    Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Catheter Cardiovasc Interv. 2020 Oct 16. doi: 10.1002/ccd.29335.
    PubMed     Abstract available


  624. GOEL R, Cao D, Chandiramani R, Roumeliotis A, et al
    Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29314.
    PubMed     Abstract available


  625. MASDJEDI K, van Zandvoort LJ, Balbi MM, Nuis RJ, et al
    Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting.
    Catheter Cardiovasc Interv. 2020 Oct 6. doi: 10.1002/ccd.29311.
    PubMed     Abstract available


    September 2020
  626. PIRIOU PG, Bonin M, Huchet F, Letocart V, et al
    Standardized fractal bench test evaluation of coronary stents: Performances in bifurcation lesions treated by the re-proximal optimization technique.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29288.
    PubMed     Abstract available


  627. FEMIA G, Faour A, Assad J, Sharma L, et al
    Comparing the clinical and prognostic impact of proximal versus nonproximal lesions in dominant right coronary artery ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Sep 1. doi: 10.1002/ccd.29245.
    PubMed     Abstract available


    August 2020
  628. D'ENTREMONT MA, Laferriere C, Berube S, Couture EL, et al
    The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
    Catheter Cardiovasc Interv. 2020 Aug 29. doi: 10.1002/ccd.29144.
    PubMed     Abstract available


  629. VELAZQUEZ MARTIN M, Montero Cabezas JM, Huertas S, Nuche J, et al
    Clinical relevance of adding intravascular ultrasound to coronary angiography for the diagnosis of extrinsic left main coronary artery compression by a pulmonary artery aneurysm in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29194.
    PubMed     Abstract available


    February 2020
  630. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Long-term effect of remote ischemic conditioning on infarct size and clinical outcomes in patients with anterior ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28760.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.